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“Nothing in life is to be feared, it is only to be understood. Now is the time to 
understand more, so that we may fear less.”
– Marie Curie
To my mother, 
for your enduring patience

ABSTRACT
Background and aims
The life-time risk for a woman to undergo pelvic floor reconstructive surgery due 
to prolapse or incontinence is 20% and the high risk for recurrence after prolapse 
surgery is a major challenge. Surgical reconstruction of the perineal body is com-
monly performed, although studies assessing results of this procedure are scarce. 
Mid-urethral sling surgery has a cure rate of 80%, but whether the sling endures 
a subsequent delivery is largely unknown. In this thesis we aimed to investigate 
whether the choice of suture material has an impact on vaginal wall prolapse 
repair; whether cervical amputation results in similar cure rates in comparison 
to vaginal hysterectomy in women with uterine prolapse; if a subsequent deliv-
ery jeopardizes results from incontinence surgery; if physiotherapy and surgical 
treatment is equally effective in women with symptoms related to a poorly healed 
second-degree perineal tear.
Methods and main results
Study I and II are both register-based cohort studies based on data from the 
Swedish National Quality Register for Gynecological Surgery (GynOp). In Study 
I, 731 women who underwent primary anterior colporrhaphy and 384 women who 
underwent primary posterior colporrhaphy were included. We found a significantly 
lower rate of women reporting vaginal bulging symptoms one year after anterior 
colporrhaphy if a slowly absorbable monofilament suture was used compared 
to a more rapidly absorbable multifilament suture, 22% vs 30% (aOR 1.6, 95% 
CI 1.1-2.3). There was no difference between the suture groups in the posterior 
colporrhaphy cohort. In Study II, women with uterine prolapse who had under-
gone either cervical amputation (n=1979) or vaginal hysterectomy (n=1195) were 
analyzed. There were no differences between the two groups regarding neither 
symptom relief nor patient satisfaction at one year after surgery. Vaginal hyster-
ectomy was associated with a higher rate of severe complications compared to 
cervical amputation, 1.9 % vs 0.2 % (p < 0.001). 
Study III is a cross-sectional, survey-based study. National registers were used to 
identify women with a delivery subsequent to a mid-urethral sling procedure (n=207) 
and a matched control-group including women without childbirth after a mid-urethral 
sling procedure (n=521). Validated questionnaires investigating urinary symptoms 
were mailed to the study participants. Patient reported stress urinary incontinence 
was present in 22% of the women with a delivery after a mid-urethral sling procedure 
and in 17% of the women in the control group (aOR 1.2, 95% CI 0.7-2.0). Vaginal 
childbirth after mid-urethral sling surgery did not increase the risk of stress urinary 
incontinence compared to cesarean delivery. 
Study IV is a randomized controlled trial where 70 women with a poorly healed 
second degree perineal tear, minimum six months post-partum, were randomized 
to either surgery or tutored pelvic floor muscle therapy. In an intention-to-treat 
analysis with worst case outcome imputation, treatment success at 6 months follow-
up was significantly more frequent in the surgery group, 71% vs 11%, p<0.001. 
Conclusions
In conclusion, the use of slowly absorbable monofilament sutures in anterior col-
porrhaphy was associated with a lower risk of symptomatic prolapse at one year 
postoperatively, compared to more rapidly absorbable multifilament sutures. In 
women with uterine prolapse, cervical amputation seems to result in similar patient 
reported outcomes as compared to vaginal hysterectomy, but comes with a lower 
risk of severe complications. Childbirth after a mid-urethral sling procedure does 
not increase the risk for recurrent stress urinary incontinence and the mode of a 
subsequent delivery does not seem to impact continence status. Finally, surgical 
treatment was superior to pelvic floor muscle therapy in providing symptom relief 
in women with poorly healed second-degree perineal tears.
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11 INTRODUCTION
Urogynecology is a cross-disciplinary medical field dedicated to the care and 
management of functional pelvic floor disorders. The umbrella term pelvic floor 
disorders (used in the present thesis) is often used to describe conditions such as 
pelvic organ prolapse (POP), urinary incontinence (UI), anal incontinence (AI), 
pelvic floor muscle dysfunction, and various structural sequalae to the pelvic floor 
anatomy after childbirth. 
Pelvic floor disorders share etiological and pathophysiological pathways and often 
co-exist or present with overlapping symptoms. Further, surgical treatment of one 
condition may affect symptoms of another condition, for example may POP sur-
gery unmask occult stress urinary incontinence (SUI). The multifactorial origins 
of pelvic floor disorders is complex and involves an interaction between heredi-
tary and environmental risk factors, as well as, a delay of symptom onset. Known 
risk factors that may be shared between different conditions such as POP, UI and 
AI include trauma at childbirth, menopause, aging, obesity and pelvic surgery.1 
Other risk factors that may influence the occurrence of pelvic floor disorders are 
for example smoking, physical labor, connective tissue disorders and chronic con-
stipation or cough,1 whereas genetic factors seems to have a considerable impact 
on both POP and SUI.2,3
Pelvic floor disorders also share common consequences and burden patients with 
often severe implications for daily function, social interactions, personal hygiene, 
sexuality, and mental wellbeing.4 Thus, the consequences of pelvic floor dysfunc-
tion may impact and interfere with a wide range of aspects of women’s individual 
quality of life.
The estimated risk for a woman to undergo at least one reconstructive pelvic floor 
procedure during her lifetime is around 20%.5,6 Unfortunately, recurrence of both-
ersome symptoms after surgery is common, and re-operation rates are as high as 
27-30%.7,8 In Sweden, 8,500 POP operations, 4,500 mid-urethral sling (MUS) 
procedures and 2,100 perineal reconstructions were performed in 2018.9 Female 
pelvic floor dysfunction may thus be considered a public health problem and the 
already significant annual costs for pelvic reconstructive surgery will most likely 
double during the next decades because of an aging population.10,11 The overarch-
ing aim of this thesis has been to identify variables that could optimize outcomes 
in women who undergo surgical treatment for symptoms related to pelvic floor 
dysfunction.
22 BACKGROUND
2.1 FUNCTIONAL PELVIC FLOOR ANATOMY
2.1.1 Levator ani and the endopelvic fascia 
A band of connective tissue extends from the pubic bone to the ischial spines and 
forms the arcus tendineus fascia pelvis (ATFP), also known as the tendinous arch. 
The tendinous arch acts like a cable of a suspension bridge and provides attachment 
points for the supporting tissues of the pelvic floor. The levator ani muscle, which 
forms the muscular floor of the pelvis and plays a crucial role in supporting the 
female pelvic organs, consists of the iliococcygeus and the pubococcygeus muscle. 
The pubococcygeus muscle runs from the sacrum to the pubis and the anterior por-
tion of the tendinous arch. The puborectalis forms a sling behind the anorectum and 
is an important structure in maintaining anal continence. By contracting, it pulls 
and sharply angulates the rectum, and when relaxing, the angle of fecal flow is 
straighter allowing evacuation. Various muscle subdivisions reflect the attachments 
of the muscle to the urethra, vagina, perineum, anus and rectum (pubourethralis, 
pubovaginalis, puboperinealis, puboanalis and puborectalis). The opening within 
the levator ani, through which the urethra and vagina pass, is called the urogenital 
hiatus. The muscles are contracted at rest and close the urogenital hiatus. The ili-
ococcygeus muscles arise from the tendinous arch and attach to the coccyx. Fibers 
from the iliococcygeus, pubococcygeus and puborectalis muscles fuse to form the 
levator plate acting as a shelf, which the pelvic organs rest on. When the body is 
in vertical position, the levator plate thus supports the rectum and upper two thirds 
of vagina. The muscles contain a majority of type I striated muscle fibers, which 
maintain a constant resting tone over time. Smaller portions of type II fibers permits 
the muscle to respond quickly to increases in intra-abdominal pressure.12 
 
PPM, puboperineal muscle
PB, perineal body
PAM, puboanal muscle
PRM, puborectalis muscle
ICM, ilicoccygeys muscle
ATLA, tendineous arch
EAS, endoanal sphincter
Figure 1. The levator ani muscle complex. Reprinted with permission from John DeLancey.
3The endopelvic fascia is a fibromuscular tissue layer surrounding the vagina. 
It attaches the vaginal walls to the tendinous arch, and coalesces at the vaginal 
apex to create the cardinal and uterosacral ligaments. The cardinal and uterosa-
cral ligaments pull the vagina toward the sacrum, suspending it over the levator 
ani muscle plate. The pubocervical fascia has been described as a fibromuscular 
sheet supporting the anterior compartment, extending from the pubic bone along 
the anterior vaginal wall to the cervix, and laterally attaching to the tendinous 
arch. The rectovaginal fascia supports the posterior compartment analogous to the 
pubocervical fascia in the anterior compartment. The rectovaginal fascia extends 
from the perineal body, toward the tendinous arch and superiorly fuses with the 
cardinal and uterosacral ligaments. 
Figure 2. The endopelvic fascia. Reprinted with permission from Cleveland Clinic Center © 2004.
42.1.2 The perineal body and the urogenital diaphragm
The perineal body is a soft tissue mass between the vagina and the anorectum, 
formed by a convergence of the tendinous attachments of multiple pelvic floor 
muscles.13 Thin-sliced magnetic resonance imaging (MRI) and cadaver dissec-
tion studies has shown that the bulbocavernosus muscle, the superficial and deep 
transverse perineal muscle, the internal and external anal sphincters as well as 
the puboperinealis and puboanalis portions of the puborectalis muscle all attach 
to the perineal body.14-16 The bulbocavernosus muscles cover the superficial parts 
of the vestibular bulbs and the major vestibular glands. They consist of striated 
muscles15,17 and run from the body of the clitoris, beneath the labia majora sur-
rounding the vaginal orifice, inserting in the upper and lateral part of the perineal 
body.18 By contracting they cause a narrowing of the vaginal orifice and by com-
pressing the deep dorsal vein of the clitoris, they contribute to female erection.19 
Some authors have suggested that the perineal body is an important part of the 
“orgasmic platform”.13
The superficial transverse perineal muscles run horizontally from the ischial 
tuberosities, attaching to the central part of the perineum. Together with the deep 
transverse perineal muscles they fix the perineal body to the bony pelvis and pre-
vent downward descent of the rectum.19 The posterior part of the perineal body is 
connected to the external and internal anal sphincter complex. The external anal 
sphincter is a voluntary, striated, circular muscle that plays a crucial part in anal 
continence.20 
Figure 3. The female perineal body. Reprinted with permission from Cleveland Clinic Center 
© 2018.
5If the perineal body becomes injured, the rectovaginal fascia may lose its caudal 
anchoring point. This results in a distal rectocele, with entrapment of stool in a 
rectal pouch just behind the sphincter complex. The rectum consequently protrudes 
into or out of the vaginal orifice during evacuation efforts.21 
The urogenital diaphragm, located between the superficial perineal body muscles 
and the levator ani muscles, is a triangle shaped muscle layer created by urethral 
sphincter muscles and the deep transverse perineal muscles. The urogenital dia-
phragm is confined among a superior and an inferior layer of fascia. The inferior 
layer of fascia is often called the perineal membrane. The compressor urethrae 
inserts anteriorly into the perineal body and the perineal body is thus intimately 
associated with the levator ani and the urethral sphincter muscles.14 The integrity 
of the perineal body is suggested to play a role in maintaining urinary continence.13 
2.1.3 Levels of support
In 1992 DeLancy described three levels of vaginal support.22 Level I suspends the 
upper third of the vagina and is supported by the uterosacral and cardinal ligaments. 
Level II is the middle third of the vagina and is supported by the endopelvic fascia, 
including the pubocervical and rectovaginal fascia, and attaches laterally to the ten-
dinous arch. Level III is the most distal portion, which is supported by the levator 
ani muscles and the perineal body. The perineal body acts as the final mechanism for 
preventing prolapse beyond the hymen.
Figure 4. Levels of support according to Johan DeLancey. Reprinted with permission 
from the author.
62.2 PELVIC ORGAN PROLAPSE
2.2.1 Epidemiology and risk factors
POP is defined as the descent of the anterior or posterior vaginal wall, the uterus, 
or the vaginal vault after hysterectomy. Estimates of the prevalence of POP in a 
population varies according to the definition of  the condition. There is, however, 
no clear consensus on what level of prolapse represents a variation of normal sup-
port and what represents a medical disorder. The following definition of clinically 
relevant POP has been suggested to reflect both anatomical abnormality and subjec-
tive bother: the descent of one or more vaginal compartments beyond the hymen on 
straining examination associated with feeling or seeing a bulge from the vagina.23 
Where POP is defined based entirely on symptoms (vaginal bulging) the prevalence 
ranges between 5-10%.24-27 When using anatomical findings, the prevalence of POP 
ranges between 30-75% 28-30 with only 3%-10% of women having the leading edge 
of the prolapse at or beyond the hymen 31,32. Anterior compartment prolapse is the 
most frequently reported site of prolapse.29,33 The lifetime risk of undergoing at least 
one surgical procedure for POP range from 6-19%.6,7,34 The etiology of POP is mul-
tifactorial and many risk factors have been suggested.35 Well established risk factors 
include vaginal childbirth, advancing age, obesity and family history.1 Increasing 
number of childbirths seems to increase the risk of POP (figure 5).1 MRI studies by 
DeLancey have demonstrated levator ani muscle defects after vaginal childbirth and 
the same author found an OR of 7.3 for having levator ani defects in women with POP 
compared to women with normal support.36,37  In the SWEPOP study by Gyhagen 
et al, vaginal delivery was associated with a 255% increased risk of POP compared 
with caesarean section and POP increased 3% with each unit increase of body mass 
index (BMI).38 Other risk factors for POP include Caucasian or Hispanic ethnic-
ity, hysterectomy and other pelvic surgery, heavy lifting and chronic constipation.1
Figure 5. The relative risk for prolapse and urinary incontinence as a function of the 
number of vaginal deliveries (adopted from Rotveit and Mant et al) and reprinted with 
permission from John DeLancey.
72.2.2 Symptoms and signs 
The most specific symptom, which strongly correlates to POP is ”seeing” or 
”feeling” a vaginal bulge.31,39-41 The hymen seems to be an important cut off level 
regarding presence of symptoms, since women with a prolapse protruding to or 
below this point are more likely to report vaginal bulging.30,42 Other mechanical 
symptoms such as vaginal pressure and heaviness or local discomfort have only 
weak correlations with objective POP.41,43 Lower urinary tract symptoms (LUTS), 
bowel emptying dysfunction, as well as, sexual dysfunction are common  among 
women with POP.42 However, these symptoms are more unspecific for POP and 
do not necessarily correlate with compartment-specific defects.40,43,44 Progressively 
worsening anterior compartment prolapse lowers the risk of SUI and increases the 
likelihood of obstructed voiding symptoms due kinking of the urethra.45 Women 
undergoing surgical repair of POP have a 9-51% risk of developing de novo SUI 
postoperatively, which may be a consequence of surgery correcting urethral kink-
ing and thus unmasking incontinence.46 
From a biomechanical perspective it would be logical that posterior vaginal wall 
prolapse results in bowel emptying difficulties (straining, splinting and feeling of 
incomplete emptying). Many studies have, however, failed to demonstrate this 
relationship 47-50, while other studies do support this association 51-54. Most studies 
have not found a dose-response effect, in terms of higher stages of posterior vaginal 
wall prolapse resulting in increasing symptoms of obstructed defecation.41,51,52,55 
AI share the same risk factors as POP, such as muscular and neuropathic injury 
caused by vaginal delivery and age. AI may co-exist but is not considered a symp-
tom specific for POP.39 
Diagnosing and grading the severity of POP involves a clinical gynecological 
examination with evaluation of the vaginal anatomy. The pelvic organ prolapse 
quantification system (POP-Q) is an objective tool for describing, quantifying, and 
staging pelvic support in women.34 It has been shown to have good intra- and inter-
examiner reliability.56 The position of each compartment is determined at maximum 
Valsalva, with the patient in a lithotomy position. The hymen is the fixed point of 
reference defined as point zero. There are six anatomic points in the vagina measured 
in centimeters above (negative numbers) or beyond (positive numbers) the hymen. 
An additional three points of measure are registered describing the total vaginal 
length, genital hiatus and the perineal body. In a multicenter observational study of 
1,004 adult women who presented for annual gynecological exam the prevalence 
of POP-Q stage 0 was 24%, stage I 38%, stage II 35%, and stage III 2% . In total, 
75% of women had some degree of POP based on the POP-Q system.30 
82.2.3 Surgical management
Colporrhaphy is the most common surgical procedure for repair of anterior and 
posterior vaginal wall prolapse.57 Colporrhaphy involves a transvaginal incision 
of the vaginal wall and dissection of the bladder or the rectum from the vaginal 
mucosa. Fibromuscular tissue in the vaginal sulci are perforated with sutures and 
adapted in the midline. Finally, excess mucosa is excised and the vaginal mucosa 
is closed with sutures. 
Figure 6. Anterior colporrhaphy with midline plication. Reprinted with permission from 
Cleveland Clinic Center © 2002-2013.
The lack of a standardized definition for treatment success after POP surgery has 
resulted in highly variable cure rates.58-60 When strict anatomic criteria (POP-Q 
stage 0 or I) are used to define success, cure rates of native tissue prolapse repair are 
as low as 30-64%.61-63 However, a substantial proportion of women in the general 
population without symptoms of POP would not meet these criteria.30 Absence of 
vaginal bulge symptoms postoperatively strongly correlate with patient’s assess-
ment of overall improvement, treatment success, as well as, with improvement 
in quality of life.60 When subjective cure or the anatomic criteria “no prolapse 
beyond hymen” are used to define treatment success, cure rates are considerably 
better (82%–94%).63 
The majority of POP recurrences occur within the first year postoperatively, of 
which anterior vaginal wall prolapse is the most common site for recurrence.8,64 
To address this limitation, biomaterial implants aiming to reinforce native tissue, 
became increasingly popular in POP surgery during the late 90´s. Reports on 
long-term side effects related to transvaginal synthetic meshes, such as erosion 
9and pain, have however turned this trend.65 Native tissue repair is therefore widely 
considered the first-line approach in vaginal wall prolapse surgery.66 Nonetheless, 
colporrhaphy is far from a standardized procedure.67 There are very few trials 
assessing details of the surgical technique used for colporrhaphies and it remains 
important to identify surgical factors that may optimize the result.
Surgical management of uterine prolapse varies greatly and currently no evidence-
based guidelines exist to guide the surgeon when choosing between the different 
apical suspension procedures.66 Vaginal hysterectomy has traditionally been the 
most common approach in the treatment of uterine prolapse 7 but uterus-preserving 
procedures are now gaining popularity 68,69. Minimally invasive sacrohysteropex-
ies provide a cure rate of up to 95%.70 These techniques, however, require both 
high-technology operating facilities as well as experienced surgeons. Other uterus 
preserving techniques include sacrospinosus fixation, with or without mesh, and 
procedures including amputation of the cervix with concurrent vaginal wall plica-
tion, also referred to as the Manchester procedure. 
2.2.4 The wound healing process and the choice of suture 
material
The wound-healing process can be divided into three phases, the exudative phase 
(1–4 days), the proliferative phase (5–20 days), and the remodeling phase (21 days 
to 2 years).71,72 The first step in connective tissue repair takes place in the second 
phase and during this period the tissue regains 15–30% of its original tensile 
strength. The tissue gains maximum tensile strength during the third phase. The 
biomechanical properties of most suture materials are described and summarized 
in a review article by Pillai et al.73 Tensile strength is a measure of a material or 
tissue’s ability to resist deformation and breakage. Absorbable multifilament sutures 
such as Vicryl® or Polysorb® have a tensile strength of 75% at 14 days, 50% at 
21 days and are totally absorbed within 70 days. The more slowly absorbable 
monofilament sutures, for example PDS®, withholds more than 50% of its tensile 
strength for up to 4 weeks and is totally absorbed within 180 days. Another pos-
sible benefit of the monofilament sutures is the lower risk of bacterial adherence 
to the suture material,74 which could decrease the risk of wound infection, wound 
dehiscence and delayed healing. Theoretical advantages of a slowly absorbable 
monofilament suture (for example PDS®) are therefore its delayed absorption, 
providing support while native tissue is healing, and its presumed lower risk of 
postoperative infection. The hypothesis that slowly absorbable monofilament 
sutures would result in better results after prolapse repair compared to the use 
of absorbable multifilament sutures is, however, sparsely tested in clinical trials.
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2.3 URINARY INCONTINENCE
UI is defined as a complaint of any involuntary leakage of urine. SUI is defined as 
the complaint of involuntary loss of urine on effort or physical exertion, sneezing 
or coughing in the absence of detrusor contraction. Urgency urinary incontinence 
(UUI) is defined by involuntary loss of urine associated with urgency (complaint of 
a sudden, compelling desire to pass urine which is difficult to defer). A combination 
of these two incontinence types are referred to as mixed urinary incontinence (MUI).
2.3.1 The urinary continence mechanism and pathophysiology  
of stress urinary incontinence
The female urethral anatomy is described in a review article by Mistry et al.75 Two 
smooth muscle layers: an inner longitudinal and an outer thinner circular layer, are 
present throughout the upper four fifths of the urethra. The smooth muscles are 
innervated by the autonomous nervous system and are surrounded by striated muscles 
referred to as the external urethral sphincter, which extends from the bladder neck 
to the perineal membrane. The external sphincter can be divided into three distinct 
muscles:  the sphincter urethrae, which surrounds the proximal two thirds of the 
urethra, the compressor urethrae and the urethrovaginal sphincter, both of which 
originate from the vaginal wall and the ischiopubic ramus and envelope the distal 
third of the urethra. During rest, submucosal vessels, connective tissue and smooth 
muscle seal off the lumen. During increased intra-abdominal pressure, for example 
when coughing or sneezing, adjunctive forces add additional support by activat-
ing voluntary muscles of the pelvic floor, such as the external urethral sphincter 
muscles and parts of the levator ani muscle. Damaged sphincters, support systems 
(fascia and levator ani muscles) or sensory innervation are all potential causes of UI.
It is widely accepted that SUI may arise as a consequence of two different pathophysi-
ological mechanisms. Bladder neck hypermobility or hypermobility of the urethra 
is caused by the lack of mid-urethral support.76 Paraurethral fascia attaches laterally 
to the tendinous arch and creates a hammock-like support.77 The pubourethral liga-
ment, which attach the urethra to the pubic bone, the sub-urethral vaginal hammock 
and the levator ani muscles all contribute to maintaining urinary continence.78 The 
muscles contract and pull the sub-urethral hammock against the pubourethral liga-
ment, thus closing off the urethra.79 The supporting structures may weaken or become 
damaged due to vaginal childbirth, obesity or inherent connective tissue weakness. 
Consequently, the proximal urethra and the bladder neck descend and rotate away 
and out of the pelvis at times of increased intra-abdominal pressure.80 Hypermobility 
is sometimes defined as a downward displacement of the urethra with a maximal 
straining angle of ≥30° from baseline. This opens the urethral lumen and small 
amounts of urine can leak out. Another pathophysiological mechanism that may be 
a cause of SUI is intrinsic sphincter deficiency (ISD), where the urethral sphincter is 
unable to generate enough pressure to retain urine in the bladder, especially  during 
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increased intra-abdominal pressure.81 There is no standardized definition for ISD, 
however, some authors suggest that the diagnosis is made by the finding of a maxi-
mal urethral closure pressure < 20 cm H2O or abdominal leak point pressure of < 60 
cm H2O on urodynamic testing.82 The urethra in ISD patients usually has little or no 
mobility and these patients may leak continuously or with minimal exertion. ISD is 
commonly associated with pelvic surgery, hypoestrogenism and aging.83 
2.3.2 Epidemiology and risk factors 
There is no consensus on an epidemiologic definition of incontinence. Most studies 
reporting a prevalence of “any UI” have figures ranging between 25% to 45% and 
for “daily UI” between 5% and 15%.1 MUI and UUI are the dominating inconti-
nence types in older women, while young and middle-aged women generally report 
SUI.1 In a cross-sectional analysis of 1,961 non-pregnant, non-institutionalized 
US women (≥20 years) by Nygaard et al, where UI was defined as moderate to 
severe leakage, the prevalence of UI was 16%.84 The EPINCONT study from 2000 
is the largest epidemiological survey carried out on UI to date including 27,936 
women.85 The overall prevalence of urinary incontinence, defined as any leakage, 
was 25 % showing a clear correlation  with increasing age. Furthermore the study 
showed a peak prevalence in mid-life with a prevalence of 30% among women 
50–54 years of age and half of the incontinent women experienced symptoms 
of SUI alone. The fraction of SUI symptoms was at its highest among women 
between 25-49 years of age, which means that a considerable number of women 
with SUI are of childbearing age. 
Well established risk factors for urinary incontinence include age, pregnancy and 
obesity.1,86 The relative risk of incontinence doubles after the first vaginal delivery as 
compared to women who are nulliparous and further deliveries may add to the risk.87 
The SWEPOP study demonstrated that the risk of developing UI was 71% higher 
after one vaginal delivery compared to caesarean section. Other risk factors for UI 
are family history, diabetes, oral estrogen treatment in women age 55 and older, hys-
terectomy, physical and cognitive dysfunction and White, non-Hispanic ethnicity.1
Figure 7. Prevalence and distribution of types on UI in different age groups (Hunskar et 
al, Urology, 2003).
12
2.3.3 Symptoms and signs
Women affected by UI often restrict their daily and social activities due to fear 
of unpleasant odor or embarrassing urine loss in public.88 Patient-reported symp-
toms, and how these impact daily life, are important both as a primary end-points 
in determining the severity of UI, and in assessing treatment outcomes.89 Urinary 
symptoms can be evaluated in clinical research using validated condition specific 
questionnaires. The Symptom and Quality of Life Assessment Committee of the 
International Consultation on Incontinence has performed a detailed review of the 
literature regarding methods used to diagnose the type and severity of UI.90 The 
report includes questionnaires with high levels of psychometric testing, that are 
recommended for use in research and clinical practice.  UI can also be defined by 
frequency, severity (a combination of frequency and quantity) or by impact (extent 
of bother or by the degree to which it restricts different activities).  
One objective sign of SUI is a so called positive cough stress test.91 The patient’s 
bladder is filled up to 300 ml and then, in lithotomy position, the patient is asked 
to perform a series of forceful coughs. The external urethral meatus is observed 
for urine loss and if this is noted the test is positive. The cough stress test has 
demonstrated good sensitivity and specificity in the diagnosis of genuine stress 
incontinence.92 Pad testing is another non-invasive method for detecting and quan-
tifying severity of urine leakage.93 The test includes measuring the weight gain 
of absorbent pads during a test period. Urine loss can be quantified with a fair 
degree of reliability, but provide no information on the underlying  incontinence 
mechanism.92 Urodynamics are used to evaluate the pressure-flow relationship 
between the bladder and the urethra by assessing the filling, storage and voiding 
phase as well as urethral dynamics. The purpose of urodynamics is to aid in the 
correct diagnosis of lower urinary tract dysfunction based upon its pathophysiology. 
Provocative tests can be added aiming to recreate symptoms and assess character-
istics of urinary leakage. Urodynamic tests may change clinical decision making 
but does not seem to result in improved outcomes after treatment.94
2.3.4 Surgical treatment
Ulmsten et al. published their initial paper about retropubic tension-free vaginal 
tape (TVT) in 1996.95 Given the minimally invasive nature and effectiveness of the 
procedure, the use of synthetic mid-urethral slings (MUS) has since been broadly 
adopted and are widely considered as the gold standard procedure for SUI in 
women, regardless of pathophysiology. 96 The procedure involves introduction of 
a polypropylene tape (approximately 1 cm in width) beneath the mid-portion of 
the urethra. The needles are passed either from the vagina through the retropubic 
route, exiting through a suprapubic incisions, or from the vaginal incision through 
the obturator membrane exiting true the groin. The sling functions as a backboard 
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that offers resistance beneath the urethra during increases in intraabdominal pres-
sure, but is tension-free at rest mimicking the pubourethral ligament. The most 
recent Cochrane review (2017) on MUS operations for SUI concluded that both 
routes result in similar objective and subjective cure rates in short and medium 
term.97 However, results from the four trials assessing reoperation rates after 
more than five years from the initial MUS procedure favored the retropubic route 
(RR 8.79, 95% CI 3.4-23.0). The 55 randomized trials included in the Cochrane 
review showed a pooled subjective cure of 84%. A 17-year, multicenter, observa-
tional study of 90 patients showed an objective cure rate of 90% and subjective 
cure rate of 77%, suggesting that the results are largely sustainable over time.98 
Mid-urethral slings are also effective in treating SUI caused by ISD, however, in 
these patients the retropubic route seems to  result in higher subjective cure rates 
compared with the trans-obturator route.99 The synthetic tapes come with a mesh 
erosion rate of 2%.97
Figure 8. Retropubic and transobturator MUS locations. Reprinted with permission from 
copyright holder Scott Bodell. 
As an alternative to surgery, non-invasive (conservative) options include pelvic 
floor muscle training (PFMT), continence devices, and electrical stimulation. 
Supervised PFMT was compared with MUS as primary treatment of moderate to 
severe SUI in a multicenter randomized controlled trial of 460 women by Labrie 
et al.100 The results from the intention-to-treat analysis showed a subjective suc-
cess rate of 91% of women in the surgery group and 64% of women in the physi-
otherapy group. A recent Cochrane review suggest that PFMT should be included 
as a first-line conservative management program for women with SUI, although 
sustainability of achieved results at long-term are poorly investigated.101
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2.3.5 Childbirth after mid-urethral sling surgery
Most physicians recommend delaying UI surgery until childbearing has been 
completed.102 Plans for future pregnancies has been regarded as a relative con-
traindication for SUI surgery.103 However, the scientific evidence to support this 
notion, as well as, recommendations to perform an elective caesarean section if 
pregnancy occurs after a MUS procedure, are based on small case series includ-
ing sample sizes of 32 to 54 women.104-107 The rate of SUI in these series have 
ranged between 70-80% in women having given birth after MUS surgery. None 
of the studies included a control group (non-exposed women) and the duration 
of follow-up was limited. Owing to the limited data  one may conclude that there 
is insufficient scientific evidence to guide counseling of women on the safety of 
childbirth after incontinence procedures. 
2.4 PERINEAL BODY INJURIES
2.4.1 Perineal tears
The classification system of perineal injuries created by Abdul Sultan is widely used 
and adopted by the Royal College of Obstetrics and Gynaecology.108 According to 
this classification a first-degree injury involves perineal skin only; a second-degree 
injury involves the perineal muscles (bulbocavernosus and superficial transverse 
perineal muscles) but not the anal sphincter; a third-degree injury involves  the 
external sphincter or both the external and internal sphincters; and a fourth-degree 
injury goes all the way through the anal mucosa.
Although much attention has been paid to the impact of third and fourth degree 
lacerations, very few studies have evaluated the consequences of a poorly sutured 
or healed second degree perineal tear. In a qualitative study by Karlström et 
al, seven women with poorly healed second degree perineal tears after child-
birth, eligible for reconstructive surgery (perineorrhaphy), were interviewed.109 
Symptoms reported by the patients were a sensation of a wide/open vagina (and 
related symptoms such as vaginal flatulence, vaginal soreness, tampons falling 
out, water entering the vagina when bathing/swimming), a sensation of vaginal 
heaviness, and bowel emptying difficulties with a need for digital assistance at 
defecation. Many women reported sexual dysfunction with symptoms such as 
orgasmic dysfunction and loss of sensation and dyspareunia. To date, there are no 
published validated questionnaires designed specifically for patients with poorly 
healed grade two perineal lacerations.
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2.4.2 Surgical reconstruction of the perineal body 
– perineorrhaphy
Perineorrhaphy means suture plication of the perineum and is sometimes used 
synonymously with perineoplasty (perineal reconstruction).  It is performed as 
either stand-alone surgery or with concomitant vaginal or abdominal POP pro-
cedures. However, the indication for performing a perineorrhaphy is not stand-
ardized and significant heterogeneity exists in the technique used to perform the 
procedure.110 Many clinicians agree that a perineorrhaphy takes place distal to the 
hymen approximating the bulbocavernosus muscles and the transverse perineal 
muscles in the midline of the perineum using absorbable sutures. If a repair of the 
posterior vagina is performed above this point, it is defined as a posterior colpor-
rhaphy.110 There are very few studies on which to base preoperative counseling of 
patients regarding benefits and possible adverse effects of secondary reconstruc-
tive surgery of the perineum.  
Ulubay et al. described anatomical changes, patient satisfaction and sexual func-
tion in 38 women undergoing perineorrhaphy.111 In this study patient satisfaction 
rate was 88% and a total of four patients (10%) reported de novo dyspareunia 
postoperatively. Pardo et al. performed vaginal wall repair and perineoplasty in 
women with the sensation of a wide vagina and reported a patient satisfaction rate 
of 96% at six months after surgery.112 Inan et al. studied 40 women undergoing 
perineoplasty in a Turkish clinic and found that sexual function scores improved 
significantly.113 These studies have some major limitations, of which the lack of a 
control group is the most important drawback. Further, the authors have not used 
validated instruments for outcome assessments nor have possible changes in dif-
ferent pelvic floor dysfunction symptoms been assessed. 
2.5 QUESTIONNAIRES - THEORETICAL ASPECTS
Questionnaires are objective tools to measure subjective phenomena, such as pel-
vic floor dysfunction symptoms and their impact on quality of life. The validation 
process means that studies have to be conducted in order to test different aspects, 
so called psychometric properties, of a questionnaire. Validity refers to the extent 
to which a questionnaire actually measures what we intend to measure. Content 
or face validity refers to if the questionnaire makes sense to those being measured 
and to experts in the clinical area, and whether the questionnaire includes important 
aspects of the condition. Construct validity reflects the relationship between the 
questionnaire and its underlying theories. Criterion validity is the degree to which 
a test measures what it claims to be measuring and can be tested by comparing 
the results from the questionnaire with “gold standards” of making a diagnosis. 
Reliability is an extent to which the questionnaire produces the same results on 
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repeated trials. Test-retest correlation provides an indication of stability over time. 
Internal consistency concerns the extent to which items within the questionnaire 
are related to each other. It is also important that questionnaires aiming to assess 
outcomes can show that they are responsive to change in an appropriate way. 
The ICS has reviewed all available questionnaires for assessing urinary incontinence 
and other pelvic floor dysfunction symptoms.90 Questionnaires were highly recom-
mended and given a grad A if the committee found data supporting that the question-
naire is valid, reliable and responsive to change. Validated questionnaires available in 
Swedish are: Pelvic Floor Distress Inventory (PFDI), Pelvic Floor Impact Questionnaire 
(PFIQ), Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ), 
Urogenital Distress Inventory (UDI), Urogenital Impact Questionnaire (IIQ) and 
International Consultation on Incontinence Questionnaires (ICIQ).
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3 AIMS OF THE THESIS
The overall aim of this thesis has been to identify variables that could optimize 
outcomes for women who undergo surgical treatment for symptoms related to 
pelvic floor dysfunction.
We specifically aimed:
Study I: To investigate if using slowly absorbable monofilament sutures is 
superior to absorbable multifilament sutures with regard to treat-
ment success after anterior and posterior colporrhaphy. 
Study II: To compare patient-reported outcomes, perioperative morbidity 
and adverse events after cervical amputation versus vaginal hys-
terectomy in women suffering from uterine prolapse.
Study III: To assess the possible consequences of childbirth on SUI in 
women who previously underwent mid-urethral sling surgery and 
to evaluate if symptoms differ with regard to mode of delivery.
Study IV: To compare and evaluate subjective and objective outcomes after 
perineorrhaphy versus tutored pelvic floor muscle therapy in 
women with a poorly healed second degree perineal tear.
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4 MATERIALS AND METHODS
4.1 SUMMARY OF STUDY DESIGNS
Study I and II are register-based cohort studies based on data retrieved from The 
Swedish National Register for Gynecological Surgery (GynOp). Study III is a 
cross-sectional survey based study and Study IV a randomized controlled study. 
Table 1 summarizes the study designs according to the PICOT format.114
Table 1. Overview of the studies in this thesis summarized according to the PICOT format
Study Study design Population Intervention Comparison Outcome Time
I. Does the 
choice of 
suture mate-
rial matter 
in anterior 
and posterior 
colporrhaphy?
Register-
based cohort 
study
Adult 
women 
undergo-
ing primary 
anterior or 
posterior 
colpor-
rhaphy
Use of slowly 
absorbable 
monofilament 
suture in the 
midline plica-
tion of the 
fascia
Use of 
rapidly 
absorbable 
multifilament 
suture in the 
midline pli-
cation of the 
fascia
Patient 
reported 
sensation 
of a vaginal 
bulge
One 
year
II. Cervical 
amputation 
versus vaginal 
hysterectomy; 
a population-
based register 
study 
Register-
based cohort 
study
Adult 
women 
with uterine 
prolapse
Vaginal hys-
terectomy 
± anterior 
colporrhaphy
Cervical 
amputation 
± anterior 
colporrhaphy
Patient 
reported 
sensation 
of a vaginal 
bulge
One 
year
III.  
Associasions 
between 
childbirth and 
urinary incon-
tinence after 
mid-urethral 
sling surgery
Population-
based cross-
sectional 
study
Adult 
women 
with a pre-
vious MUS 
procedure
Childbirth after 
MUS proce-
dure (both 
vaginal and 
cesarean)
No childbirth 
after MUS 
procedure
Patient 
reported 
stress 
urinary 
incontinence
Cross-
sectional
IV.  
Perineorrhaphy 
compared with 
pelvic floor 
muscle ther-
apy in women 
with late con-
sequences of a 
poorly healed 
second-degree 
perineal tear: 
a randomized 
controlled trial
Randomized 
controlled, 
open-label 
trial, with two 
parallel arms
Adult 
women 
with a 
poorly 
healed 2nd 
degree per-
ineal tear 
minimum 
6 months 
postpartum
Perineorrhaphy 
with distal 
posterior 
colporrhaphy
Tutored 
pelvic floor 
muscle 
therapy
Treatment 
success 
defined by  
the Patient 
Global 
Impression 
of 
Improvement 
Scale
Six 
months
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4.2 STUDY I AND II
4.2.1 Data sources 
Study I and II are population-based cohort studies based on data  retrieved from 
the Swedish National Quality Register for Gynecological Surgery (GynOp), 
that prospectively collects information on routine gynecological surgical care in 
Sweden. The register includes seven sections covering different surgical areas of 
gynecology (hysterectomies, adnexal procedures, gynecological tumor surgery, 
hysteroscopy and endometrial ablation, third and fourth degree perineal tears, as 
well as, POP and SUI surgery). The register was established in 1994 and collec-
tion of data regarding POP surgery started in 2006. In 2011 a total of 43 out of 
53 (81%) gynecological clinics in Sweden participated in the register. The clinics 
situated in the county of Stockholm, Värmland and Gotland reported to a different 
quality register called GKR (Gynekologiskt Kvalitetsregister). In 2012, however, 
data from the GKR was merged into the GynOp register. Currently a total of 61 
clinics report to the register. During 2007 to 2010, the board of the Gynop-register 
conducted an inspection visit to a total of 15 clinics (both university and county 
hospitals). They found that the mean proportion of patients included in the regis-
ter was 96% of all eligible patients. All Swedish national quality registries have 
so called certification levels of which there are four levels. The levels represents 
how far the register has reached in terms of analyses, inclusion of relevant vari-
ables, coordination with health services, use in research, data quality and reporting, 
coverage rate, as well as, technical solutions. The GynOp register has the highest 
possible rating (certification level 1).115
Data in the register are collected through patient questionnaires and forms com-
pleted by surgeons. The Swedish Urogynaecology Association (UR-Arg) is respon-
sible for part of the content of these forms. The surgical coordination nurse or a 
secretary at the gynecological department includes the patients and provide them 
with written information about the register and an option to decline participation. 
All data extracted from the register for analysis is encoded. Since 2006 patients 
receives two follow-up questionnaires, one at two months and the other at one 
year postoperatively. 
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4.2.2 Study population
Study I includes two separate cohorts. The first cohort (n=1,107) includes adult 
women with a stage II-III prolapse of the anterior vaginal wall (anterior vaginal 
wall -1 to + 4 cm in relation to the hymen) having had an isolated anterior colpor-
rhaphy, and no other concomitant procedure, where the surgeon used either rapidly 
absorbable multifilament  sutures (RA sutures) or slowly absorbable monofila-
ment sutures (SA sutures) in the midline plication of the fascia. The second cohort 
(n=577) includes women with similar inclusion criteria but with a prolapse of the 
posterior vaginal wall. Exclusion criteria in both cohorts were: previous pelvic 
floor surgery or hysterectomy; prolapse stages II–IV in another compartment; or 
a uterus larger than 12 weeks’ of gestational age. The operations were performed 
between September 2012-2013 since registration of suture materials in the regis-
ter begun in September 2012. Flow chart of the study populations are illustrated 
in Figure 9-10.
Meeting inclusion criteria 
(n = 1107)
Responded to primary
outcome question at 1 year
(n = 731)
Rapidly absorbable suture
(n = 501)
Slowly absorbable suture
(n = 230)
Excluded (n = 376)
did not respond primary outcome
question 
Meeting inclusion criteria 
(n = 577)
Responded to primary
outcome question at 1 year
(n = 384)
Rapidly absorbable suture
(n = 258)
Slowly absorbable suture
(n = 126)
Excluded (n = 193)
did not respond primary outcome
question 
Figure 9. Flow chart of the anterior  
colporrhaphy cohort
Figure 10. Flow chart of the posterior  
colporrhaphy cohort
Study II consists of 4,047 adult women with uterine prolapse POP-Q stage I–IV 
having had either cervical amputation or vaginal hysterectomy, with or without 
concomitant anterior colporrhaphy (figure 11). Exclusion criteria includes previous 
prolapse or urinary incontinence surgery, a uterus larger than 12 weeks’ gestation, 
and concomitant posterior colporrhaphy.
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Eligable for the study
n=4047
Included in the 
analysis (responders)
n=3174 (78%)
Cervical amputation
n=1979 (62%)
With anterior
colporrhaphy
n=1757 (89%)
Without anterior
colporrhaphy
n=222 (11%)
With anterior
Vaginal hysterectomy
n=1195 (38%)
colporrhaphy
n=1013 (85%) 
Without anterior
colporrhaphy
n=182 (15%)
Excluded
(non responders)
n=873 (22%)
Figure 11. Flow chart of the study participants in Study II
4.2.3 Exposures and co-variates
In Study I the exposures were two different types of sutures that are used for midline 
plication of the pubocervical or rectovaginal fascia during a colporrhaphy. Since 
September 2012 the variable “suture material” has been a part of the mandatory 
variables recorded by the surgeon. We compared rapidly absorbable multifila-
ment sutures (Vicryl®, Polysorb®) with slowly absorbable monofilament sutures 
(PDS®, Maxon®). In order to adjust for possible confounding factors two dif-
ferent regression models were used. A model adjusting for age, functional status 
(ASA class), BMI, parity, menopausal status, and preoperative degree of prolapse 
resulted in 54% missing subjects, and the sample size was therefore significantly 
reduced. This model was used as a sensitivity analysis. A model including age 
(being an important risk factor for POP) and functional status (since there were 
significant differences in ASA class at baseline) included no missing values and 
were therefore used as the main analyses. The variables age, preoperative degree 
of prolapse and ASA class were collected from forms completed by the surgeon, 
whereas the variables BMI, parity and menopausal status were collected from 
preoperative questionnaires completed by the patient. 
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In Study II the main exposures were vaginal hysterectomy and cervical amputa-
tion performed on prolapse indication. Both procedures were, in the majority of 
cases, performed with a concomitant anterior colporrhaphy. The regression model 
adjusted for the following co-variates: age, parity, BMI, preoperative degree of 
anterior and apical compartment prolapse (according to the POP-Q), concomitant 
anterior colporrhaphy, bulging symptoms at baseline, and menopausal status.
4.2.4 Outcome measures
The primary outcome in both Study I and II was patient-reported vaginal bulging 
symptoms at the 1-year follow-up questionnaire. The question “Do you experi-
ence a feeling of bulging or protrusion in the vaginal area?” was dichotomized 
from five answer options (never and hardly ever into “no” and 1–3 times per 
month, 1–3 times per week or daily into “yes”). Secondary outcomes included 
patient-reported satisfaction, changes in urinary and bowel symptoms and sexual 
activity. Questions concerning urinary and bowel symptoms were recoded from 
five answer options into three (never and hardly ever into “never”, 1–3 times per 
month and 1–3 times per week into “sometimes” and daily remained as “daily”). 
Sexual activity was assessed with the question “Have you had coitus in the past 
3 months?” (yes or no). Secondary endpoints also included patient and doctor 
reported complications. 
In Study II we manually went through a description of every single doctor or 
patient reported severe complication in order to specify each severe complica-
tion. We categorized them as “severe complications” only if they matched the 
criteria of a grade 2 complication as defined by the Clavien-Dindo classifications 
system.116 In Study II we also compared perioperative variables such as operation 
time, blood loss, days at hospital etc. 
4.2.5 Post publication sensitivity analyses of Study I
A study published in 2018 by Bohlin et al. reported on factors influencing outcomes 
of anterior and posterior vaginal wall prolapse surgery, based on data from the 
GynOp register.117 Patients were considered “cured” if they reported vaginal bulging 
sensation “never”, “hardly ever” or “1–3 times per month” at 1 year after surgery 
(we categorized 1-3 times per month into “non-cured”). Recently published stud-
ies have shown that factors associated with prolapse recurrence are: preoperative 
degree of prolapse,118,119 levator ani injuries,119,120 family history,119,120 age (inverse 
correlation),120 BMI,117,120,121 parity,118 co-morbidities118 and preoperative degree of 
bulging symptoms117. We have therefore subsequently tested the robustness of our 
results by performing additional sensitivity analyses. We performed multivariate 
logistic regression of the primary outcome in a model adjusting for preoperative 
degree of prolapse and bulging symptoms, age, BMI, parity and ASA class (as 
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a proxy for co-morbidities). The analyses are performed with both original data, 
as well as, with multiple imputation of missing values. We have also tested the 
robustness of our conclusion by re-categorizing the cutoff for cure versus non-
cure as defined by Bohlin et al.
4.3 STUDY III
Study III is a population-based cross-sectional study comparing women with and 
without childbirth subsequent to MUS surgery.
4.3.1 Data source
In Study III we used data from nationwide health care registers supervised by the 
Swedish Board of Health and Welfare. The Swedish Medical Birth Register was 
founded in 1973 and includes data on 99% of all deliveries in Sweden. The Patient 
Register has complete national coverage from 1987 and includes all inpatient 
care in Sweden. Since 2001 the register also covers outpatient care, including day 
surgery, from both private and public caregivers. The inpatient register has been 
validated  and has less than 1% yearly missing registrations and correct coding 
for surgical procedures is achieved in 98% of cases.122 The missing registration 
rates in the outpatient register has been reduced from 25-30% during the first 
year (2001) to only 4% in 2016. The register contains data on individual hospital 
discharges and surgical procedure codes according to the Swedish Classification 
of Surgical Procedures. The records also contain dates of admission, discharge, 
and date of surgery. Using national registration numbers, our exposed and unex-
posed cohorts (ie, women who had and had not undergone childbirth subsequent 
to MUS surgery) were linked.
4.3.2 Study population
The study population includes adult women with at least one delivery, either 
vaginal or cesarean, after a mid-urethral sling procedure (exposed group) and a 
matched control group including women without any deliveries after their MUS 
procedure (non-exposed group). The study subjects were identified by linking 
individual records from the Patient Register with the Medical Birth Register. We 
identified a total of 207 exposed women, who had undergone a MUS procedure 
between 2002 and 2014, and had one or more subsequent deliveries. For every 
woman in the exposed group, we then randomly identified a maximum of three 
controls (n=521) per case. The women in the control group had no deliveries 
after their MUS procedure and they were matched to the women in the exposed 
group by year of surgery and age at surgery. A flow chart of the study population 
is presented in figure 12.
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Figure 12. Flow chart of the study population.
4.3.3 Exposures and co-variates
The study subjects were defined as exposed if they had a registered retropubic or 
trans-obturator sling operation (procedure codes LEG 10 and 13) in the Patient 
Register, and a subsequent delivery (vaginal or cesarean) registered in the Medical 
Birth Register. The control group was identified using an identical selection pro-
cess. Matching on age and year at time of surgery was done in order to control for 
important confounders. In June 2016, questionnaires were mailed to all identified 
study subjects. In November 2016 a reminder was sent out to non-responders. 
The questionnaire included UDI and IIQ-7 questionnaires, as well as questions 
regarding demographic variables (length, current weight, smoking status, parity, 
mode and year of deliveries, comorbidities, including psychiatric disorders and 
current medications, previous gynecological procedures, re-operation of a MUS).
4.3.4 Outcome measures
The long version of the UDI and the short version of the IIQ (IIQ-7) were used to 
assess bother from possible lower urinary tract symptoms and their impact on quality 
of life. The primary outcome in this study was patient reported SUI. Presence of 
SUI was defined by patient answering “moderate” or “great” on the question: “Do 
you experience urine leakage related to physical activity, coughing or  sneezing?” 
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(UDI). No symptoms or only little bother from symptoms were categorized as 
no SUI. Secondary outcomes included the total UDI score, UDI subscale scores, 
and IIQ-7 scores. We also tested whether different demographic variables were 
associated with the primary outcome (presence of bothersome SUI). The exposed 
group were asked to answer additional questions about if they needed catheteri-
zation during the pregnancy after their MUS procedure and if the previous MUS 
procedure was an indication for cesarean delivery in the subsequent pregnancy. 
4.3.5 Urogenital Distress Inventory and Incontinence Impact 
Questionnaire
UDI is a questionnaire developed in 1994 by Shumaker et al.123 It includes 19 
items and is divided into three subscales reflecting the presence and bother from 
different aspects of urogenital dysfunction: SUI symptoms, irritative symptoms, 
and obstructive symptoms. The score from each subscale ranges from 0 to 100, 
with a maximum summary score of 300. Higher scores indicate greater dysfunc-
tion. The IIQ was developed in 1995 by the same research group and includes 30 
questions. The IIQ was designed to assess what effect urinary incontinence has 
on daily activities and emotions in women. A short form consisting of seven items 
(IIQ-7) has proven to accurately predict the IIQ long-form total score.124 The score 
calculated from the IIQ-7 ranges from 0 to 100 with, higher scores indicating 
greater effect on quality of life. The UDI and IIQ have been shown to significantly 
correlate with the number of UI episodes and pads used per week.125  It has been 
suggested that the UDI-6 (the short form of the 19 item questionnaire) provides 
predictive results of urodynamic findings.126 The ICS Committee has given Grade A 
level of validity to the UDI questionnaire for assessing UI and OAB symptoms.127 
4.3.6 Power calculation
Previous studies has shown a SUI prevalence of 20 % in women with childbirth 
after a MUS procedure.104,106 A Swedish study on long-term outcomes after MUS 
procedures, without subsequent deliveries, reported a durable cure rate of up to 
90 %.128 A 10 percentage-points difference could be considered clinically relevant. 
According to these assumptions we needed 133 exposed and 399 unexposed sub-
jects in order to have 80 % power to detect a significant difference between the 
groups regarding the primary outcome (assuming a 5 % two-sided significance 
level). Anticipating a non-response rate of at least 15 %, a total of 157 and 470 
needed to be invited to participate.
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4.4 STUDY IV
Study IV is a randomized controlled, open label trial with two parallel arms com-
paring surgery and physiotherapy in women with a poorly healed second degree 
perineal tear.
4.4.1 Setting
The patients included in the trial came on routine internal or external referral to 
the urogynecological outpatient clinic at the South General Hospital in Stockholm, 
Sweden. No specific patient advertisement was used. After enrollment, all inter-
ventions and follow-ups were carried out at the OBGYN Department at the South 
General Hospital.
4.4.2 Study population 
A total of 70 patients with perineal defects were enrolled in the study. Patients 
eligible for the study were adult women seeking help due to bothersome pelvic 
floor dysfunction symptoms and who had a perineal injury (detachment of the 
bulbocavernosus and/or the transversus perinei muscles), were a perineorrhaphy 
with distal posterior colporrhaphy was indicated. Other inclusion criteria were; 
maximal perineal thickness of 2 cm on bidigital palpation, no indication for con-
comitant pelvic floor surgery, minimum 6 months postpartum and completion 
of exclusive breastfeeding as well as return of menstruation. Exclusion criteria 
were; history of a previous forth degree laceration, a connective tissue disorder, 
current use of systemic corticosteroids, diabetes mellitus, occult sphincter tear on 
ultrasound or indication for sphincter muscle reconstruction, previous pelvic floor 
surgery, concomitant pelvic-organ prolapse in the anterior or apical compartment 
of POP-Q stage 2 or worse. 
4.4.3 Randomization and interventions
Eligible patients who consented to participate in the study were randomized in an 1:1 
ratio into receiving either surgical repair or conservative treatment. Randomization 
was performed without stratification in balanced blocks of four, using a web-based 
tool. All eligibility criteria were checked with an electronic checklist during rand-
omization. The randomization table was designed by an independent statistician.
Patients who were randomized into surgical treatment were scheduled for perineor-
rhaphy with distal posterior colporrhaphy. The surgical procedure was standardized 
prior to initiation of the study. The procedures were performed in local anesthesia as 
day surgery by one of five different pelvic floor surgeons. After informed consent 
from one of the study participants, the surgical procedure was recorded in order to 
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illustrate the technique.  Patients who were randomized into conservative treatment 
were referred to one of two different pelvic floor physiotherapists at the OBGYN 
outpatient clinic at South General Hospital. They received an initial evaluation 
of the pelvic floor muscle strength and a tutored session with pelvic floor muscle 
exercises. The patients then received a pelvic floor exercise program to help them 
build up 10 maximal contractions, each 5 seconds long, three times per day and 
one maximal contraction 30-60 seconds. They were scheduled for 1-3 follow ups 
visits depending on the whish from the patient to receive further biofeedback. 
4.4.4 Outcome measures
Outcome measures were collected at baseline (initial visit at randomization) and 
at a 6 months follow-up visit. The primary outcome was treatment success defined 
as patient choosing answer options “much better” or “very much better” on the 
Patient Global Impression of Improvement scale (PGI-I) at the 6 months follow-up 
visit. PGI-I is a seven grade Likert scale where the patient is asked to assess her 
subjective level of improvement ranging from very much worse up to very much 
better. Secondary outcomes included comparison of changes in the Pelvic Floor 
Distress Inventory (PFDI-20), plus three non-validated questions regarding vaginal 
symptoms, and the Pelvic Floor Impact Questionnaire (PFIQ-7), as well as the 
Prolapse Incontinence Sexual Questionnaire (PISQ-12) and the Hospital Anxiety 
and Depression Scale (HAD). Objective outcome measures included an anatomical 
description of the pelvic floor according to the POP-Q system and evaluation of 
the perineal body thickness using both ultrasound and bidigital palpation. Surgical 
characteristics, complications and adverse events during follow-up were registered 
in a separate protocol.
4.4.5 Power calculation
The current literature does not support a robust formal sample size calculation 
for the primary outcome of interest. Our power analysis is therefore based on the 
assumption that 60% in the surgery group and 20% in the physiotherapy group 
reports subjective cure. According to these assumptions we needed 28 patients in 
each arm in order to have an 80% power to detect a significant difference between 
the groups regarding the primary outcome (assuming a 5% two-sided significance 
level). Anticipating a 20% loss to follow-up a total of 70 (35 in each arm) needed 
to be recruited.
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4.5 STATISTICS
Baseline characteristics of the comparative groups are in all four studies summarized 
using standard descriptive statistics. Continuous variables are presented as means 
(± SD) or medians (range or inter-quartile range) and categorical variables as fre-
quencies. For comparison of baseline variables we used the Mann–Whitney U test 
when analyzing continuous data and Fisher’s exact test for categorical variables. 
Categorical endpoints in Study I, II and III were analyzed using univariate and 
multivariate logistic regression, dichotomized outcomes with binary regression and 
multiple answer outcomes with the proportional odds model. Results of the logistic 
regression analyses are presented as odds ratios with 95 % confidence intervals. 
Comparison of outcomes within groups in Study I, II and IV were analyzed using 
the Wilcoxon signed rank test for continuous or ordinal variables and McNemar 
tests for dichotomized categorical variables. 
In Study IV, the primary analysis were undertaken on an intention-to-treat (ITT) 
basis and compared with results of a per protocol analysis. The principal ITT 
analysis was performed with worst case imputation of missing outcomes (assuming 
treatment failure). A sensitivity analysis was performed with original data and by 
imputation of missing data with multiple imputation (10 iterations). An as-treated 
approach was used when assessing perioperative data and safety. Effect sizes (odds 
ratios with 95% confidence intervals) of the primary outcome were calculated using 
univariate logistic regression. Categorical endpoints were compared with Fishers 
exact test and continuous outcomes are analyzed using the Mann–Whitney U test.
A p value of <0.05 was considered significant for all comparisons. Statistical 
analyses were performed using SPSS version 22 and 23 software (IBM, Armonk, 
NY, USA). All statistical analyses and models were designed and conducted in 
cooperation with one of the three biostatisticians at our institution. 
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5 RESULTS
5.1 STUDY I
5.1.1 Patient characteristics
The response rate to the primary outcome question at one year postoperatively was 
66% in both cohorts. There was no difference in baseline characteristics between 
responders and non-responders (data not shown). The RA suture group included 
women undergoing colporrhaphy, where the surgeon used either Vicryl® (n=351) 
or Polysorb® (n=150) and the SA suture group included the sutures PDS® (n=225) 
and Maxon® (n=5). Baseline characteristics of the study population in the anterior 
colporrhaphy cohort are presented in Table 2 and of the posterior colporrhaphy 
cohort in Table 3. In both cohorts, the two suture groups were similar regarding 
all variables except for functional status (ASA class). The SA suture group in both 
cohorts had relatively more patients with higher ASA classes.
Table 2. Baseline characteristics of the 731 study participants in the anterior 
colporrhaphy cohort 
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Table 3. Baseline characteristics of the 384 study participants in the posterior  colporrhaphy 
cohort
5.1.2 Outcomes
There were no significant differences in pelvic floor dysfunction symptoms at 
baseline between the groups. The SA suture group had a significantly lower rate 
of vaginal bulging symptoms (primary outcome) at one year postoperatively com-
pared to the RA suture group; 50/230 (22 %) versus 152/501 (30 %), adjusted OR 
1.6, 95% CI 1.1-2.3, p = 0.01. Patient-reported satisfaction was also better in the 
SA suture group, 83% were satisfied with the result compared with 75% in the 
RA suture group (p = 0.03). Improvement of both bladder and bowel symptoms 
occurred within both groups. Urinary  urgency improved significantly more in the 
RA suture group (p<0.001). There were no differences between the two suture 
groups regarding all other bladder and bowel symptoms. 
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In the posterior colporrhaphy cohort there was no significant difference between 
the two suture groups regarding the primary outcome, vaginal bulging, at one year 
after surgery. Vaginal bulging was reported by 21% in the SA suture group and by 
20% in the RA suture group (p=1.0). There was no difference in patient reported 
satisfaction or any of the pelvic floor dysfunction symptoms.  There were no sig-
nificant differences in complications reported by the patient or the surgeon, neither 
in the anterior nor in the posterior colporrhaphy cohort.
5.1.3 Post publication sensitivity analyses of Study I
We have tested the robustness of our conclusions in the anterior colporrhaphy 
cohort by performing a multivariate regression model adjusting for co-variates that 
have been reported to increase the risk of recurrence; age, parity, BMI (in WHO 
categories <25, 25-29, >30), ASA class (as a proxy for co-morbidities), preop-
erative degree of prolapse and bulging symptoms. The adjusted OR with original 
data, which included 26% missing cases, was 1.6 (95% CI 1.04-2.7), p=0.035. The 
adjusted OR with imputed data (multiple imputation with 10 iterations) was 1.8 
(95% CI 1.2-2.7), p=0.008. Changing the cut-off for cure according to the defini-
tion by Bohlin et al117 resulted in 85% cured in the SA group and 75% cured in 
the RA group. A comparison between the suture groups using the new cut off and 
the above described regression model did not alter the results.
5.2 STUDY II
5.2.1 Patient characteristics
Baseline characteristics of the final study population available for analysis (n=3,174) 
are presented in Table 4. A greater number of women in the cervical amputation 
group were postmenopausal and concomitant anterior colporrhaphy was somewhat 
more common in the cervical amputation group. The vaginal hysterectomy group 
had higher POP-Q stages of the apex and the anterior wall at baseline (figure 13).
Figure 13. Vaginal hysterectomies in relation to cervical amputations at different stages 
of uterine prolapse.
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Table 4. Baseline characteristics of the study population (n=3174)
Characteristics VH group  (n = 1195)
CA group  
(n = 1979)
p-value
Age at surgery (yr) mean (±SD) 63.2 (± 10.4) 63.1 (± 10.5) 1.0 
Body mass index (kg/m²) mean (±SD) 25.9 (± 4.1) 25.8 (± 3.8) 0.6 
Parity median (range) 2 (0-10) 2 (0-10) 0.1 
Cesarean sections median (range) 0 (0-3) 0 (0-3) 0.4
Current smoker n (%)
Yes 118 (11) 158 (10) 0.3
No 960 (89) 1461 (90)
Estrogen replacement therapy n (%)
Yes 67 (6) 87 (5) 0.4 
No 1049 (94) 1591 (95)
Postmenopausal n (%)
Yes 800 (77) 1284 (81) 0.03 
No 236 (23) 307 (19)
Functional status (ASA class) n (%)
I 699 (58) 1203 (61) 0.5
II 464 (39) 731 (37)
III 32 (3) 44 (2)
POP-Q stage apex n (%)
I 44 (5) 134 (9)
II 381 (45) 776 (55) <0.001
III 338 (40) 459 (32)
IV 81 (10) 49 (4)
POP-Q stage anterior wall n (%)
I 38 (5) 89 (6) <0.001
II 351 (43) 716 (52)
III 359 (44) 536 (39)
IV 75 (9) 47 (3)
Concomitant anterior colporrhaphy n (%)
Yes 1013 (85) 1757 (89) 0.001
No 181 (15) 222 (11)
5.2.2 Outcomes
Both groups improved significantly regarding all pelvic floor dysfunction symp-
toms and also became more sexually active (Table 5). A comparison of symptom 
improvement and patient satisfaction at one year are presented in Table 6. A total of 
81% in both groups reported absence of vaginal bulging at follow-up. There were 
no significant differences in patient satisfaction rates (89% vs. 89%). An analysis of 
the primary outcome i.e. vaginal bulging at one year, stratified by stage of prolapse, 
showed no differences between the groups. Variables associated with the primary 
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outcome were age and BMI. Patients with vaginal bulging postoperatively were 
somewhat younger (mean age ± SD; 61.5 ± 10.5 vs 63.4 ± 10.3, p = 0.001) and had 
a higher BMI (mean BMI ± SD; 26.2 ± 4.3 vs 25.7 ± 3.8, p = 0.04). When women 
reporting vaginal bulging 1-3 times per month at follow-up were re-categorized 
into “no vaginal bulging”, the cure rates were 86% in the cervical amputation group 
and 87% in the vaginal hysterectomy group (aOR 1.2, 95% CI 0.9-1.7).
Table 5. Comparison of patient reported symptoms within groups. Figures are numbers (%).
Symptoms VH group 
(n = 1195)
CA group 
(n = 1979)
Preop Postop p-value Preop Postop p-value
Vaginal bulging
yes 1017 (94) 223 (19) <0.001 1686 (96) 336 (19) <0.001
no 62 (6) 972 (81) 73 (4) 1613 (81)
Satisfaction
Satisfied 1028 (89) 1714 (89)
Neither nor 90 (8) 134 (7)
Dissatisfied 37 (3) 69 (4)
Straining to 
void
Never 545 (51) 999 (86) <0.001 917 (53) 1636 (85) <0.001
Sometimes 171 (16) 89 (8) 307 (18) 179 (9)
Daily 344 (33) 71 (6) 509 (29) 117 (6)
Urinary 
incontinence
Never 649 (60) 892 (76) <0.001 1069 (61) 1443 (74) <0.001
Sometimes 265 (25) 188 (16) 452 (26) 365 (19)
Daily 165 (15) 97 (8) 241 (14) 143 (7)
Urgency
Never 331 (29) 764 (66) <0.001 571 (33) 1267 (67) <0.001
Sometimes 302 (28) 249 (22) 534 (31) 432 (23)
Daily 469 (43) 144 (12) 640 (38) 193 (10)
Nocturia
0-1 times per 
night
817 (74) 975 (82) <0.001 1337 (75) 1607 (81) <0.001
≥ 2 times per 
night
288 (26) 217 (18) 448 (25) 366 (19)
Straining to defecate
Never 744 (69) 927 (79) <0.001 1230 (71) 1504 (78) <0.001
Sometimes 246 (23) 203 (17) 408 (23) 345 (18)
Daily 83 (8) 44 (4) 107 (6) 75 (4)
Digitation
Never 861 (82) 1035 (90) <0.001 1436 (84) 1728 (90) <0.001
Sometimes 131 (12) 95 (8) 200 (12) 147 (8)
Daily 63 (6) 28 (2) 72 (4) 34 (2)
Sexually active
No 632 (59) 577 (52) <0.001 1042 (59) 986 (53) <0.001
Yes 448 (41) 534 (48) 715 (41) 879 (47)
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Table 6. Comparison of patient reported postoperative symptoms between groups. Figures 
are numbers (%).  
Symptoms VH groupa 
(n = 1195)
CA group 
(n = 1979)
Postop Postop OR (95% CI)b c, p-value
Vaginal bulging
Yes 223 (19) 336 (19) 1.0 (0.7-1.3) 0.8
No 972 (81) 1613 (81)
Satisfaction
Satisfied 1028 (89) 1714 (89) 1.1 (0.8-1.5) 0.6
Neither nor 90 (8) 134 (7)
Dissatisfied 37 (3) 69 (4)
Straining to void
Never 999 (86) 1636 (85) 0.8 (0.6-1.1) 0.2
Sometimes 89 (8) 179 (9)
Daily 71 (6) 117 (6)
Urinary 
incontinence
Never 892 (76) 1443 (74) 1.0 (0.8-1.3) 0.9
Sometimes 188 (16) 365 (19)
Daily 97 (8) 143 (7)
Urgency
Never 764 (66) 1267 (67) 0.9 (0.8-1.2) 0.6
Sometimes 249 (22) 432 (23)
Daily 144 (12) 193 (10)
Nocturia
0-1 times per 
night
975 (82) 1607 (81) 0.9 (0.6-1.2) 0.4
≥ 2 times per 
night
217 (18) 366 (19)
Straining to 
defecate
Never 927 (79) 1504 (78) 1.1 (0.8-1.3) 1.0
Sometimes 203 (17) 345 (18)
Daily 44 (4) 75 (4)
Digitation
Never 1035 (90) 1728 (90) 1.1 (0.9-1.5) 0.3
Sometimes 95 (8) 147 (8)
Daily 28 (2) 34 (2)
Sexually active
No 577 (52) 986 (53) 1.0 (0.8-1.4) 0.8
Yes 534 (48) 879 (47)
a reference 
b modulated towards negative values 
c adjusted for age, parity, body mass index (BMI), degree of anterior and apical compartment 
prolapse, concomitant anterior colporrhaphy, symptoms at baseline and menopausal status.
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5.2.3 Adverse events
Severe complications were more common in the hysterectomy group as compared 
to the cervical amputation group, 23/1,195 (1.9 %) versus 4/1,979 (0.2 %), p < 
0.001. Severe complications in the hysterectomy group were: intra-abdominal 
bleeding (n = 8), severe intra-abdominal infection or sepsis (n = 7), ureteric injuries 
(n = 4), bowel injuries (n = 2), myocardial infarction (n = 1), and severe complica-
tions related to anesthesia (n = 1). Severe complications in the cervical amputa-
tion group consisted of: severe bleeding (n= 2) and severe infection (n = 2). The 
rate of doctor reported mild to moderate complications were similar between the 
groups, 146 out of 1,195 (12.2 %) in the vaginal hysterectomy group versus 246 
out of 1,979 (12.4 %) in the cervical amputation group, p = 0.9. 
The hysterectomy group had a significantly longer mean duration of surgery (76.2 
vs 50.0 min, p < 0.001), greater mean amount of blood loss (100.1 vs 44.6 ml, p < 
0.001) and received prophylactic antibiotics as well as prophylaxis against venous 
thrombosis to a greater extent.  The hysterectomy group had also a longer hospi-
talization (1.7 vs 0.8 days, p < 0.001) and a longer period until return to normal 
activities of daily living (6.1 vs 4.8 days, p < 0.001). 
5.3 STUDY III
5.3.1 Patient characteristics
A total of 163 women with childbirth after mid-urethral sling surgery and 374 
women in the control group were included in the final analysis. A sensitivity analysis 
investigating characteristics of non-responders showed no significant differences 
regarding age, concomitant prolapse surgery and number of years postoperatively 
and postpartum. A total of 86% of the women in the study group had one delivery, 
13% had two deliveries, and 1% had three deliveries after their mid-urethral sling 
procedure. Demographic characteristics are presented in Table 7. There were no 
differences between the groups except for number of years postpartum and total 
parity. When comparing women with vaginal and cesarean delivery after a mid-
urethral sling procedure, the groups were also similar regarding demographic 
characteristics except for parity and smoking status.
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Table 7. Baseline characteristics of the study population
5.3.2 Outcomes
Patient-reported SUI was equally common among women with and without child-
birth after a MUS procedure: 22% of women with a delivery after a MUS proce-
dure reported moderately to greatly bothersome SUI in comparison to 17% in the 
control group (aOR 1.2, 95 % CI 0.7-2.0). When we changed the cutoff for SUI 
to include also mildly bothersome symptoms, a total of 48% of the women in the 
exposed group reported SUI compared with 45% in the unexposed group (aOR 1.0, 
95% CI 0.6–1.5).  Vaginal delivery in comparison to cesarean section after a MUS 
procedure did not increase the prevalence of SUI. A total of 22% in both groups 
reported SUI (aOR 0.6, 95% CI 0.2–1.4). Variables associated with the presence 
of SUI symptoms were obesity (BMI 30 or greater), psychiatric disorder, history 
of a secondary MUS or POP procedure (Table 8). The overall subjective success 
rate in women with a repeat sling procedure was 68%. We found no significant 
difference in patient reported SUI rates when comparing women with one delivery 
(n=140) versus more than one deliveries (n=22) after their MUS  procedure, 79% 
versus 73% (aOR 1.2, 95% CI 0.3-4.7) or when comparing women with multiple 
deliveries after their MUS with the control group, 83% versus 73% (aOR 0.8, 
95% CI 0.2-2.5). 
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Table 8. Univariate and multivariate regression analysis of clinical co-variates  associated 
with SUI.
SUI*,  
n (%)
No SUI,  
n (%)
cOR 
(95% CI)
aOR 
(95% CI)
P value
Childbirth after 
MUS surgery
Yes 36 (22) 127 (78) 1.4 (0.9-2.2) 1.2 (0.7-2.0) 0.50
No 63 (17) 308 (83) Ref Ref
Body Mass 
Index, kg/m²
< 30 76 (17) 383 (83) Ref Ref
≥ 30 23 (34) 45 (66) 2.6 (1.5-4.5) 2.7 (1.5-4.5) 0.001
Parity
1-2 48 (15) 263 (85) Ref Ref
≥ 3 51 (23) 170 (77) 1.6 (1.1-2.5) 1.4 (0.9-2.3) 0.17
Smoker
Yes 7 (16) 38 (84) Ref Ref
No 92 (19) 394 (81) 1.3 (0.5-2.9) 1.5 (0.6-3.6) 0.38
Postmenopausal
Yes 11 (19) 48 (81) Ref Ref
No 88 (19) 384 (81) 1.0 (0.5-2.0) 1.0 (0.5-2.1) 0.94
Co-morbidity
Yes 39 (21) 148 (79) 1.3 (0.8-2.0) 1.2 (0.7-2.2) 0.54
No 60 (17) 286 (83) Ref Ref
Psychiatric 
disorder
Yes 22 (29) 54 (71) 2.0 (1.2-3.5) 2.2 (1.1-4.7) 0.04
No 77 (17) 380 (83) Ref Ref
Reoperation of 
MUS
Yes 15 (32) 32 (68) 2.2 (1.2-4.3) 2.3 (1.2-4.6) 0.02
No 84 (17) 401 (83) Ref Ref
Previous 
other prolapse 
surgery
Yes 12 (34) 23 (66) 2.5 (1.2-5.1) 2.6 (1.2-5.6) 0.02
No 87 (17) 410 (83) Ref Ref
Hysterectomy
Yes 4 (13) 26 (87) 0.7 (0.2-1.9) 0.6 (0.2-1.9) 0.36
No 95 (19) 406 (81) Ref Ref
* SUI, stress urinary incontinence
A total of 3/163 women (1.8%) reported a need for bladder catheterization during 
pregnancy subsequent to a MUS procedure. 73 of 95 (77%) women delivered by 
cesarean section after their MUS procedure reported the sling procedure being the 
indication for cesarean delivery. 
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There were no differences in UDI and IIQ-7 scores between any of the groups 
(Table 9). Figure 14 illustrates a visual comparison of the UDI domain scores and 
IIQ-7 scores in box plots, displaying medians, interquartile ranges, and outliers. 
Table 9. Comparison of Scores From the Urinary Distress Inventory and the Short Form 
of the Incontinence Impact Questionnaire 
All participants Childbirth after MUS 
surgery
Outcome 
measure
Childbirth after 
MUS surgery 
n=163
No childbirth 
after MUS 
surgery 
n=373
p 
value
Vaginal 
birth after 
MUS 
n=64
Cesarean 
section 
after MUS 
n=95
p 
value
Total UDI * 57±55 52±52 0.33 59±57 55±53 0.74
UDI-S † 22±26 20±26 0.26 24±28 20±25 0.40
UDI-I ‡ 22±22 20±20 0.60 22±24 22±21 0.72
UDI-O § 13±15 12±15 0.22 13±14 13±16 0.78
IIQ-7 || 11±19 10±19 0.41 10±19 11±20 0.70
* Reflects presence and bother from different aspects of urogenital dysfunction, higher scores indicate 
greater dysfunction. Ranges from 0-300.    
† Reflects stress incontinence symptoms. Ranges from 0-100. 
‡ Reflects irritative urinary symptoms. Ranges from 0-100. 
§ Reflects obstructive micturition and prolapse symptoms. Ranges from 0-100. 
|| Reflects impact of urinary symptoms on quality of life. Ranges from 0-100.   
   
Figure 14. Comparison of Urinary Distress Inventory (UDI) domains and Incontinence 
Impact Questionnaire (short form) (IIQ-7) scores (0–100) between the groups. UDI-S, stress 
urinary incontinence symptoms; UDI-I, irritative symptoms; UDI-O, obstructive symptoms. 
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5.4 STUDY IV
5.4.1 Patient characteristics
A total of 109 women fulfilled the eligibility criteria during the enrollment period. 
70 women gave informed, written consent to participate in the study. Figure 15 
illustrates a flow chart of the patients according to the CONSORT guidelines. Table 
10 demonstrates the baseline characteristics of the study population. There were no 
differences in baseline characteristics when comparing the two treatment groups.
Figure 15. The flow of patients through the trial according to the criteria recommended 
in the CONSORT Guidelines.
Guidelines. 
40
Table 10. Baseline characteristics of the study population
Characteristics Surgery group n=35 Physiotherapy group n=35
Age (y) 36 (6) 33 (7)
Parity 2 (1) 2 (0)
Mode of delivery
Vaginal 2 (1) 2 (1)
Cesarean section 0 (0) 0 (0)
Months postpartum 12 (37) 9 (30)
BMI (kg/m2) 23 (5) 22 (5)
Current smoker, n (%) 3 (9) 3 (9)
Maximal degree of tear during any 
delivery, n (%)
2nd 28 (80) 30 (86)
3rd 7 (20) 5 (14)
Hormonal contraception, n (%) 5 (14) 7 (20)
PFDI  score* 80 (74) 94 (89)
PFIQ-7 score* 48 (76) 52 (57)
PISQ score* 33 (11) 32 (7)
HAD score* 10 (9) 12 (9)
Perineal body height on bidigital 
 palpation, n (%)
<1cm 15 (43) 9 (26)
1-2 cm 20 (57) 26 (74)
Perineal body height on 2D ultrasound 
(mm)
8 (3) 8 (3)
Genital hiatus (gh) (cm) 4 (0.7) 3.5 (1)
Anterior vaginal wall (Ba) (cm) - 2 (1) - 2 (1)
Posterior vaginal wall (Bp) (cm) - 2 (2) - 2 (3)
Cervix (c) (cm) - 7 (1) - 6 (2)
Total vaginal length (tvl) (cm) 9 (1) 8 (2)
BMI, Body mass index. Calculated by dividing weight in kilograms by height in meters squared.
PFDI, Pelvic floor distress inventory. Scores ranges from 0-300.
PFIQ Short form of pelvic floor impact questionnaire. Scores ranges from 0-300.
PISQ, Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire. Scores ranges from 0-48. 
HAD, Hospital anxiety and depression scale. Scores ranges from 0-21.
Data are median (interquartile range) or n (%) unless otherwise specified.
Mann–Whitney U test was used when analyzing continuous data; Fisher exact test was used for categorical 
variables. 
There were no statistically significant (p <0.05) differences between the groups at baseline.
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5.4.2 Outcomes
In the intention-to-treat analysis with worst case imputation, treatment success, 
defined as answer options “much better” and “very much better” on the Patient 
Global Impression of Improvement scale, was significantly more frequent in the 
surgery group, 25/35 (71%) versus 4/35 (11%), p<0.001. The result of the per-
protocol analysis was similar (Table 11). 
Table 11. Primary outcome in the surgery group and physiotherapy group at 6 months
Surgery 
group
Physiotherapy 
group
Treatment 
effect (95% 
CI) percent-
age points
OR (95% 
CI)
PGI-I – Intention to treat -analysis 
with worst case imputation
n=35 n=35
Treatment success 25 (71) 4 (11) 60.0 
(41.7-78.3)
19 (5-69)
PGI-I – Intention to treat -analysis 
with multiple imputation
n=35 n=35
Treatment success 27 (77) 4 (11) 65.7 
(48.3-83.2)
29 
(8-112)
PGI-I – Intention to treat -analysis 
without imputation
n=32 n=35
Treatment success 25 (78) 4 (11) 66.7 
(48.9-84.5)
27 
(7-105)
PGI-I – Per Protocol analysis n=30 n=33
Treatment success 24 (80) 3 (9) 70.9 
(53.6-88.3)
46 
(11-203)
PGI, Patient global impression of improvement. Treatment success is defined as patient 
choosing answer options “much better” or “very much better”.
OR, odds ratio; CI, Confidence Interval
Effect sizes in odds ratios with 95% confidence intervals are calculated with univariate logis-
tic regression.
Table 12 presents the secondary outcomes within both groups at baseline and at 
the 6 month follow-up visit. All questionnaire scores (including every subscale) 
among the patients receiving surgical treatment improved significantly. The 
physiotherapy group improved only in the prolapse domain of the PFDI and in 
the PISQ-12 scores (sexual function). 
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Table 12. Within-group comparison of secondary outcomes at baseline and at 6 months 
Surgery group  
n=32
Physiotherapy group 
n=35
Baseline Follow-up p-value Baseline Follow-up p-value
PFDI scores, 
total
87.0 ± 45.8 45.1 ± 47.1 <0.001 93.7 ± 50.0 81.6 ± 53.1 0.06
POPDI-6 
domain 
30.6 ± 19.6 12.9 ± 17.2 <0.001 33.9 ± 20.7 27.9 ± 20.9 0.02
CRADI-8 
domain
27.1 ± 18.8 14.1 ± 16.0 <0.001 27.5 ± 17.6 24.8 ± 18.2 0.2
UDI-6 domain 29.3 ± 20.9 18.1 ± 19.7 0.004 32.3 ± 23.8 28.9 ± 22.5 0.4
PFIQ scores, 
total
69.9 ± 56.2 26.8 ± 55.6 <0.001 63.1 ± 55.7 48.5 ± 41.6 0.1
UIQ-7 16.1 ± 22.4 6.5 ± 17.6 0.003 14.3 ± 20.9 12.7 ± 18.8 0.8
CRAIQ-7 20.8 ± 24.1 8.8 ± 19.8 0.003 18.0 ± 22.9 15.7 ± 20.1 0.8
POPIQ-7 33.0 ± 23.2 11.5 ± 21.8 <0.001 30.9 ± 21.4 20.0 ± 16.9 0.003
PISQ scores 31.5 ± 6.4 35.8 ± 7.4 0.001 32.7 ± 4.4 34.0 ± 4.7 0.02
HAD scores 11.1 ± 6.5 8.0 ± 7.5 0.005 12.2 ± 8.2 11.4 ± 6.3 0.4
Perineal body 
thickness (mm) 
on 2D ultrasound
7.9 ± 2.1 15.1 ± 2.7 <0.001 8.9 ± 2.3 9.0 ± 2.4 0.2
Perineal skin (pb) 
(cm)
1.8 ± 0.8 3.1 ± 0.5 <0.001 2.0 ± 0.6 2.1 ± 0.5 0.2
Genital hiatus 
(cm)
3.8 ± 0.6 2.9 ± 0.4 <0.001 3.6 ± 0.6 3.7 ± 0.6 0.3
Anterior vaginal 
wall (Ba) (cm)
-2.1 ± 0.7 -2.5 ± 0.7 0.009 -1.9 ± 0.8 -2.2 ± 0.8 0.002
Posterior vaginal 
wall (Bp) (cm)
-1.5 ± 1.2 -2.7 ± 0.7 <0.001 -1.6 ± 1.3 -1.5 ± 1.3 0.8
Cervix (C) (cm) -6.6 ± 0.9 -7.2 ± 1.1 0.02 -6.6 ± 1.3 -6.5 ± 2.2 0.8
Total vaginal 
length (tvl) (cm)
8.8 ± 0.8 9.4 ± 1.1 0.005 8.8 ± 1.2 9.1 ± 1.1 0.03
* Pelvic floor distress inventory. Scores ranges from 0-300. POPDI = Pelvic organ prolapse 
distress inventory. CRADI = Colorectal-Anal distress inventory. UDI = Urinary distress inven-
tory. Domain scores ranges from 0-100.
‡ Short form of pelvic floor impact questionnaire. Scores ranges from 0-300. UIQ = Urinary 
impact questionnaire. CRAIQ = Colorectal-Anal impact questionnaire. POPIQ = Pelvic organ 
prolapse impact questionnaire.
§ Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire. Scores 
ranges from 0-48. 
|| Hospital anxiety and depression scale. Scores ranges from 0-21.
Changes in anatomical landmarks are reported in millimeters.
Within-group comparisons are analyzed with Wilcoxons test.
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Table 13 shows a comparison of the delta value (follow-up value minus baseline 
value) between the two treatment groups. The surgery group was superior to the 
physiotherapy group in all aspects of symptom improvement. Table 14 demon-
strates the frequency of different pelvic floor dysfunction symptoms before and 
after treatment. None of the patients reported de novo dysparunia.
Table 13. Comparison of changes in secondary outcomes in the treatment groups. 
Surgery group 
n=32
Physiotherapy 
group n=35
Original data Imputed data
Changes in PFDI* 
scores, total
-42.0 ± 44.4 -12.1 ± 31.4 <0.001 0.001
POPDI-6 domain -17.7 ± 21.4 -6.1 ± 14.1 0.02 0.01
CRADI-8 domain -13.1 ± 16.5 -2.7 ± 12.5 0.003 0.003
UDI-6 domain -11.2 ± 18.3 -3.3 ± 18.0 0.045 0.04
Changes in PIFQ‡ 
scores, total
-43.2 ± 49.9 -9.2 ± 31.1 <0.001 <0.001
UIQ-7 domain -9.5 ± 19.2 0.3 ± 15.1 <0.001 0.02
CRAIQ-7 domain -12.1 ± 20.9 -0.4 ± 15.3 0.003 0.009
POPIQ-7 domain -21.6 ± 22.1 -9.1 ± 16.1 0.003 0.008
Changes in PISQ§ 
scores
5.1 ± 9.2 2.1 ± 4.4 0.025 0.08
Changes in HAD|| 
scores
-3.0 ± 5.6 -0.8 ± 6.5 0.04 0.047
Changes in perineal 
body thickness on 2D 
ultrasound (mm)
7.2 ± 3.1 0.1 ± 1.6 <0.001 <0.001
Changes in genital hia-
tus (Gh) (mm)
-8.3 ± 6.4 1.0 ± 5.3 <0.001 <0.001
Changes in anterior 
vaginal wall (Ba) (mm)
-6.1 ± 9.2 3.2 ± 14.2 <0.001 0.004
Changes in posterior 
vaginal wall (Bp) (mm)
-11.6 ± 13.9 0.3 ± 8.4 <0.001 <0.001
Changes in cervix (C) 
(mm)
5.4 ± 12.6 -0.9 ± 19.6 0.3 0.2
Changes in total vagi-
nal length (tvl) (mm)
5.5 ± 9.6 4.1 ± 9.9 0.8 0.6
* Pelvic floor distress inventory. Scores ranges from 0-300. POPDI = Pelvic organ prolapse 
distress inventory. CRADI = Colorectal-Anal distress inventory. UDI = Urinary distress inven-
tory. Domain scores ranges from 0-100.
‡ Short form of pelvic floor impact questionnaire. Scores ranges from 0-300. UIQ = Urinary 
impact questionnaire. CRAIQ = Colorectal-Anal impact questionnaire. POPIQ = Pelvic organ 
prolapse impact questionnaire.
§ Pelvic Organ Prolapse/Urinary Incontinence Sexual Function Questionnaire. Scores 
ranges from 0-48. 
|| Hospital anxiety and depression scale. Scores ranges from 0-21.
Changes in anatomical landmarks are reported in millimeters.
In-between group comparisons are analyzed with Mann–Whitney U test.
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Table 14. Patient-reported pelvic floor dysfunction symptoms at baseline and at 6 months. 
Pelvic floor dysfunction 
symptoms
Surgery group Physiotherapy group
Baseline 
n=35
Follow-up 
n=32
Baseline 
n=35
Follow-up 
n=35
Do you usually experi-
ence pressure in the lower 
abdomen?*
16 (46) 5 (16) 0.01 15 (43) 17 (49) NS
Do you usually experience 
heaviness or dullness in the 
lower abdomen?*
21 (60) 10 (31) 0.02 25 (71) 22 (63) NS
Do you usually have a bulge 
or something falling out that 
you can see or feel in the vag-
inal area?*
17 (49) 4 (13) 0.002 18 (51) 18 (51) NS
Do you usually have to push 
on the vagina or around the 
rectum to have a complete 
bowel movement?*
16 (46) 3 (9) 0.002 20 (57) 18 (51) NS
Do you usually experience a 
feeling of incomplete bladder 
emptying?*
20 (57) 9 (28) NS 17 (49) 12 (34) NS
Do you ever have to push up 
in the vaginal area with your 
fingers to start or complete 
urination?*
2 (6) 2 (6) NS 3 (9) 2 (6) NS
Do you feel you need to strain 
too hard to have a bowel 
movement?*
20 (57) 6 (19) 0.002 21 (60) 21 (60) NS
Do you feel you have not 
completely emptied your 
bowels at the end of a bowel 
movement?*
21 (60) 9 (28) 0.007 24 (69) 28 (80) NS
Do you usually lose stool 
beyond your control if your 
stool is well formed?*
1 (3) 0 (0) NS 1 (3) 1 (3) NS
Do you usually lose stool 
beyond your control if you 
stool is loose or liquid?*
6 (17) 3 (9) NS 2 (6) 4 (11) NS
Do you usually lose gas 
from the rectum beyond your 
control?*
17 (49) 12 (38) NS 17 (49) 16 (46) NS
Do you usually have pain 
when you pass your stool?*
14 (40) 8 (25) NS 13 (37) 13 (37) NS
Do you experience a strong 
sense of urgency and have to 
rush to the bathroom to have 
a bowel movement? *
21 (60) 10 (31) <0.001 23 (66) 17 (49) NS
Does part of your bowel ever 
pass through the rectum and 
bulge outside during or after a 
bowel movement?*
4 (11) 3 (9) NS 12 (34) 8 (23) NS
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Do you usually experience fre-
quent urination?*
14 (40) 11 (34) NS 21 (60) 22 (63) NS
Do you usually experience 
urine leakage associated with 
a feeling of urgency; that is, a 
strong sensation of needing to 
go to the bathroom?*
14 (40) 5 (16) 0.007 12 (34) 10 (29) NS
Do you usually  experience 
urine leakage related to laugh-
ing, coughing, or sneezing?*
18 (51) 10 (31) 0.005 16 (46) 15 (43) NS
Do you usually experience 
small amounts of urine leak-
age (that is, drops)?*
14 (40) 11 (34) NS 13 (37.1) 12 (34.3) NS
Do you usually experience 
difficulty emptying your 
bladder?*
8 (23) 7 (22) NS 11 (31) 9 (26) NS
Do you usually experience 
pain of discomfort in the lower 
abdomen or genital region?*
22 (63) 11 (34) 0.01 23 (66) 21 (60) NS
Do you experience a sensa-
tion of a wide or open vagina, 
n (%)†
<0.001 NS
Never 0 (0) 17 (53) 1 (3) 1 (3)
Sometimes 4 (12) 12 (38) 2 (6) 8 (23)
Daily 28 (88) 3 (9) 32 (91) 26 (74)
Do you experience air going in 
and out of the vagina , n (%)†
<0.001 NS
Never 3 (9) 14 (44) 2 (6) 5 (14)
Sometimes 14 (44) 17 (53) 14 (40) 16 (46)
Daily 15 (47) 1 (3) 19 (54) 14 (40)
Do you experience excessive 
discharge , n (%)†
0.001 NS
Never 7 (22) 20 (63) 11 (31.5) 13 (37)
Sometimes 17 (53) 9 (28) 11 (31.5) 12 (34)
Daily 8 (25) 3 (9) 13 (37) 10 (29)
Do you feel pain during sexual 
intercourse, n/total (%)‡
0.01 NS
No or seldom 9 (35) 20 (71) 14 (45) 13 (42)
Sometimes 11 (42) 4 (14.5) 11 (36) 12 (39)
Often or always 6 (23) 4 (14.5) 6 (19) 6 (19)
* Questions from the Pelvic floor distress inventory questionnaire. Answers dichotomized from 
“no symptoms” or “no bother from symptom” to “no” and from ”mildly to greatly bothersome 
symptoms” into “yes”. Patients who reported “yes” are presented in the table. 
† Non-validated questions. 
‡ Question number 5 from the Pelvic Organ Prolapse/Urinary Incontinence Sexual Function 
Questionnaire. In the surgery group a total of 26 patients answered the questionnaire at baseline 
and 28 at follow-up. The corresponding numbers in the physiotherapy group were 31 and 31. 
Changes within groups are analyzed with McNemars test
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6 DISCUSSION
6.1 THE RESULTS IN A CLINICAL CONTEXT
6.1.1 Study I
The main finding of this study was that using a slowly absorbable monofilament 
suture (for example PDS®) in anterior colporrhaphy, was associated with greater 
symptom relief and patient satisfaction at one year postoperatively as compared 
to a more rapidly absorbable multifilament suture (for example Vicryl®). A col-
porrhaphy procedure includes adaptation of fibromuscular tissue laterally in the 
vaginal sulci into the midline using sutures.  Due to sparse evidence, there is no 
consensus on which suture material to use  and the selection of suture material is 
often a decision of the operating surgeon.66 A Cochrane review on abdominal wall 
closure techniques found that slowly absorbable monofilament sutures reduced 
the risk of incisional hernia when compared with multifilament sutures (RR 0.76, 
95% CI 0.59-0.98).129 It is, however, unclear whether results from abdominal fas-
cia closure can be applied on pelvic floor fascial repair. A study by Goldstein et al 
comparing Panacryl®, Ethibond ®, Prolene® and PDS® found that braided sutures 
such as Ethibond® and Panacryl® had a much higher incidence of suture-related 
complications requiring treatment compared to monofilament sutures.130 The study 
included both absorbable as well as permanent sutures. Non-absorbable sutures in 
the vagina have shown to cause problems such as suture erosion and repeat sur-
gery due to suture removal.131 Many pelvic floor surgeons are therefore prone to 
use absorbable sutures for midline plication.67 The only previous study comparing 
PDS® and Vicryl® is a randomized controlled feasibility trial published in 2008 
by Allahdin et al. They found no differences in prolapse symptom relief or qual-
ity of life scores between the groups at follow-up. The study, however, included 
a mix of anterior, posterior and paravaginal procedures as well as concomitant 
procedures (hysterectomy, incontinence surgery). It was a feasibility study and 
therefore not sufficiently powered to detect differences between the suture groups. 
The most prevalent site for prolapse, and also for recurrence after surgical repair, 
is the anterior vaginal wall.29,33,64 Clinically relevant definitions of cure, including 
absence of symptoms (subjective cure) or no prolapse beyond the hymen, results 
in cure rates ranging between 82-96%.63 The number of cured patients in our study 
are thus comparable to previous studies where cure is defined as absence of vagi-
nal bulging. The cure rate in the anterior colporrhaphy cohort was 78% in the SA 
suture group and 70% in the RA suture group. When changing the cut-off for cure, 
by grouping women with symptoms 1-3 times per month into “cured prolapse”, 
resulted in cure rates of 85% in the SA group and 75% in the RA group. Posterior 
colporrhaphy is not as prone to failure as the anterior wall. Anatomical cure rates 
in previous reports range between 76-96%.132,133 Approximately 80% in both groups 
in our study reported absence of vaginal bulging at one year follow-up. We found 
no evidence supporting that the choice of suture material in posterior colporrhaphy 
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would matter. The intra-abdominal pressure on the surgical site might be lower 
on the posterior compartment compared to the anterior wall, which may explain 
why the tensile strength of the suture is not as crucial.134 
Urinary symptoms such as incontinence, detrusor instability and obstructed urina-
tion often co-exist with prolapse but are not as specific to POP as vaginal bulg-
ing.135 Both suture groups in the anterior cohort improved significantly regarding 
all urinary symptoms. However, urinary urge symptoms improved significantly 
more in the RA suture group. The association between POP and symptoms of 
OAB show contradictory results. Romanzi et al found that women with grade 
3-4 cystoceles were more likely to have symptoms and signs of OAB compared 
to women with lesser degrees of prolapse.136 In contrast, Burrows et al found that 
urgency and urgency urinary incontinence occurred more often in women with 
less advanced POP.137 This was corroborated in another study using ultrasound to 
grade the severity of prolapse; women with higher grade of bladder prolapse were 
less likely to suffer from urge symptoms.138 The RA suture group reporting less 
urgency at follow-up in our study might thus be explained by them having higher 
grades of postoperative prolapse.  
Previous studies have reported a 20-50% prevalence of splinting at defecation 
among women with rectocele 50,133 and 24-76% prevalence of straining 50,139,140. 
In our study, symptoms of obstructed defecation (straining and splinting) were 
more prevalent in women undergoing posterior compared to anterior repair. 
Approximately 40% in the posterior colporrhaphy cohort reported daily straining 
at defecation preoperatively and a significant reduction to 11% was seen postopera-
tively (p<0.001). The corresponding proportions of women reporting a daily need 
for manual assistance during defecation were 32% preop and 6% postop (p<0.001). 
Our findings that symptoms of obstructed defecation are more common in women 
with posterior compartment prolapse compared to other compartments, and that 
these symptoms improve after surgical correction of the anatomy, are similar to 
the findings in a study published in 2019 by Karjalainen et al.52 
6.1.2 Study II
The main finding of this study was that cervical amputation cures symptoms 
related to POP equally well as vaginal hysterectomy (VH) in women with apical 
prolapse. Subjective cure, defined as the absence of vaginal bulging, was 81% 
in both groups and the satisfaction rate was even higher (89% in both groups). 
Equality between the two procedures was found in every strata of preoperative 
prolapse stage. The relative risk for severe complication was, however, ten times 
higher in the VH group compared to the cervical amputation group. 
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Uterine prolapse is a result of failed level I support, with damage to the cardinal 
and uterosacral ligaments.22,141 The prevalence of objective uterine prolapse among 
postmenopausal women is 14%.33 Previous studies have found that anterior vaginal 
wall and apical prolapse very often co-exist (figure 16),142,143 which was evident in 
our study considering the fact that the majority of operations included a concomitant 
anterior colporrhaphy. However, isolated “one compartment only” defects do exist.142 
Figure 16. Correlation between the anterior and apical compartment prolapse. Adopted 
from Rooney AJOG. 2006.
There are many different surgical techniques to correct uterine decent and there is 
currently no consensus regarding the optimal approach.144,145 Historically, VH is the 
most commonly performed procedure for uterine prolapse.146,147 It has, however, 
been suggested that hysterectomy may cause damage to nerve supply and support-
ive structures of the pelvic floor increasing the rate of bladder dysfunction, SUI 
and POP recurrence.148-150  A normal-sized uterus itself plays minimal role in apical 
decent, and the purpose of hysterectomy at time of POP surgery is to gain access 
to tissues used for apical suspension. A systematic review with meta-analysis on 
uterine preservation versus hysterectomy in POP surgery was published in 2018.151 
The authors found that uterine-preserving procedures improved operating time 
and blood loss, lowered complication rates and had similar short-term prolapse 
outcomes compared to vaginal hysterectomy. A study assessing patient preferences 
found that a higher proportion of women with prolapse symptoms preferred uterine 
preservation, compared with hysterectomy, provided that outcomes were equal.152 
An argument for performing a hysterectomy solely due to prolapse, is that it 
eliminates the risk of an existing or future uterine or cervical malignancy. The 
prevalence of endometrial carcinoma in asymptomatic women undergoing hys-
terectomy for prolapse is 0.3-0-8.153,154 This is in line with a study by Koss et al 
who discovered a 0.7% prevalence of endometrial carcinomas diagnosed with 
endometrial biopsy in a screening program in 2,586 peri and postmenopausal 
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women.155 The background risk of incidental cancer in asymptomatic women is 
thus low. A preoperative workup with a Pap smear and endometrial ultrasound, 
plus an endometrial biopsy when indicated, could be an option in women with 
POP where uterine preservation is planned. 
The Manchester procedure (MP) was first performed in 1888 and originally included 
amputation of the cervix combined with an anterior and posterior colporrhaphy. 
In 1921 Fothergill modified the technique by suturing the cardinal ligaments 
on to the cervical stump. In 2018 Oversand et al published a prospective cohort 
study on 153 women who underwent the Manchester procedure in a Norweigan 
clinic, with a follow-up rate of 97% at one year postoperatively.156  The procedure 
included an anterior colporrhaphy, cervical amputation and uterosacral/cardinal 
ligament shortening and plication proximal to the anterior part of the cervix stump. 
A perineal body reconstruction was performed in all cases. POP-Q stage < 2 was 
obtained in 99% in the mid-compartment but only in 49% in the anterior com-
partment. 5.6% reported de novo dyspareunia and 96% reported being cured or 
significantly improved. Previous studies comparing MP with VH are summarized 
in a review article by Tolstrup et al, published in 2017.157 It included nine stud-
ies of which one was a randomized controlled trial. Both anatomical recurrence 
rates for the middle compartment and re-operation rates were higher after VH 
compared to MP. VH was associated with more perioperative bleeding, longer 
operating time and more bladder lesions and infections, which is in line with 
the findings of our study. The same authors published a matched cohort study in 
2018 on the same subject including patients with POP treated with VH (n=295) 
or MP (n=295).158 The risk for prolapse in any compartment was higher after VH 
(18.3%) compared with the MP (7.8%) with a HR of 2.5 (95% CI 1.3-4.8). There 
were more perioperative complications (2.7 vs. 0%, p = 0.007) and postoperative 
intra-abdominal bleeding (2 vs. 0%, p = 0.03) after VH. The superiority of the MP 
in comparison to VH was also found in a recently published study based on data 
from the Danish register for gynecological surgery.159 The reason why we did not 
find superior outcomes in the CA group in our study may be that the women did 
not undergo the “full Manchester repair” which includes also posterior colpor-
rhaphy. Further, the Forthergill technique, which includes suspension of the apex 
by suturing the cardinal ligaments to the cervical stump, might not be performed 
by all surgeons performing CA in Sweden.
Other uterine preserving techniques for apical prolapse are sacrospinosus liga-
ment fixation (SSLF) and abdominal (laparoscopic/robotic) sacrohysteropexy. 
Two meta-analysis analyzing results of SSLF concluded that the pooled apical 
failure rate (POPQ grade ³2) was 8.5-10% 160,161 and 13% were dissatisfied with 
the result161. The pooled failure rate after SSLF in the anterior and posterior com-
partment were 21-35% and 6-7% respectively. SSLF performs equally well in 
comparison to VH considering apical failure and re-operation rates.160 The rate of 
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visceral injuries during a SSLF was as low as 0.4%.160 The most common com-
plication after SSLF is buttock pain. It often resolves spontaneously but 4% have 
persisting symptoms 4–6 weeks postoperatively.162 Both laparoscopic and robot-
assisted sacrohysteropexies have excellent cure rates, objective ranging between 
91-94% and subjective between 92-95%.70 These procedures, however, require 
both high-technology operating facilities, as well as experienced surgeons, and 
comes with a median mesh erosion rate of 2-5% .163,164 
In summary, there are many different surgical treatment options in women with 
a prolapse of the middle compartment. No guidelines currently exist to guide the 
choice of technique. Procedures including removal of the uterus comes with a 
higher rate of serious complications and trends are turning to uterus preserving 
procedures in women with uterine decent. Sacrohysteropexies have the highest 
reported success rates but require high-technology operating facilities and expe-
rienced surgeons. This procedure also comes with higher costs, longer operation 
times and a low but yet existing risk of mesh erosions. The Manchester-Fothergill 
operation is a minimally invasive procedure with satisfactory results and low 
complication rates as compared to VH and should be considered a valid option.
6.1.3 Study III
The main finding of this study was that women who gave birth after a mid-urethral 
sling procedure (MUS) did not have a higher rate of SUI, or other urinary symptoms, 
compared to women with no deliveries after their MUS procedure. Furthermore, 
continence status was not affected by the mode of a subsequent delivery. 
Due to lack of evidence, most physicians have previously recommended delaying 
incontinence surgery until childbearing has been completed .103 Many have even 
advocated cesarean delivery to a pregnant women with a previous MUS procedure.165 
The most recent review article is published by Cavkaytar et al in 2015 includ-
ing 66 women with a delivery after a MUS procedure (53% by cesarean section 
and 47% by vaginal delivery).107 The authors found no difference in postpartum 
incontinence when comparing mode of delivery after a MUS. The prevalence of 
incontinence postpartum was 20%, which is similar to our study where 22% of 
the women with a delivery after a MUS reported SUI. In 2016 Adams-Piper et 
al. published the so far largest case series of women with a delivery after a MUS 
procedure, which included 26 cases.104 This study corroborated the findings of 
the safety and durability of a MUS after a subsequent pregnancy and delivery. 
In 2019, one year after our study was published, Dyrkorn et al published a Norwegian 
study very similar to ours, which allows for interesting comparisons.166 Their study 
included 72 women (39 vaginal deliveries, 33 cesarean sections) with and 156 
without childbirth after a MUS procedure. The median follow-up time was 10 years 
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after the initial MUS procedure, as compared to 9 years in our study. The primary 
outcome was absence of SUI, defined as having a SUI index of 0 in a validated 
condition specific questionnaire. A strength of the study was that they had data 
on continence status 6-12 months after the initial MUS procedure, which allows 
for comparison of symptoms before and after the subsequent delivery. Subjective 
cure rate of SUI was 82% in the “childbirth after MUS” group and 75% in the “no 
childbirth after MUS” group, p=0.31. When stratifying for one versus multiple 
deliveries after the MUS procedure, the authors found a significantly increased the 
risk of SUI in the multiple deliveries group (50% versus 88%, p=0.006). Mode of 
delivery after MUS surgery did not affect the outcomes, which is in line with the 
findings of our study. The “childbirth after MUS” group had a subjective cure rate 
of 93% at 6-12 months after their initial MUS procedure, which dropped to 88% 
after one subsequent delivery (p=0.3) and to 84% when including also the women 
with multiple deliveries after their MUS procedure (p=0.04). The change in SUI 
cure rates in the control group was non-significant (dropped from 77% at 6-12 
months to 75% at 10 years postoperatively). In our study 3/163 (1.8%) women 
reported a need for bladder catheterization during the pregnancy where she had a 
MUS in place compared to 1/72 (1.4%) in the Norwegian study.
Obesity is a well-established risk factor for urinary incontinence.1 However, studies 
investigating whether  obesity is a risk factor for failure after MUS surgery show 
contradictory results.167-171 Both the present study and the Norwegian study found 
that a BMI over 30 correlated with significantly higher odds of patient reported 
SUI. Another risk factor for persisting SUI symptoms, found in both our and the 
Norwegian study, was repeat surgery for SUI. These findings are in accordance 
with previous studies. Stav and co-workers compared outcomes in 1,035 women 
with a primary MUS procedure and 77 women with a repeat MUS procedure.172 
The subjective stress incontinence cure rate was 86% and 62% in the primary 
and repeat group, respectively (p <0.001). A systematic review of the literature 
on procedures for recurrent SUI was published in 2015 and included 52 studies.173 
The common characteristic of all procedures for recurrent SUI was a lower success 
rate compared to the primary procedure. Repeat mid-urethral sling procedures had 
a pooled success rate of 66.2% (95% CI ±4). In our study, the subjective success 
rate in women with a repeat sling procedure was 68%. We also found that women 
with self-reported psychiatric illness had a significantly higher rate of subjective 
SUI. Many authors have found a correlation between anxiety/depressive disorders 
and urinary incontinence.174,175 Causality and temporal order are however unclear. 
The effect of pregnancy and delivery on outcomes of MUS surgery can, for obvi-
ous reasons, never be tested in a randomized trial. The evidence guiding practice 
must therefore rely on observational studies. In summary, current evidence which is 
based on multiple case series and two relatively large cohort studies with matched 
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controls, do not find results indicating that at least one subsequent pregnancy jeop-
ardizes the results from a previous MUS procedure. Neither do they find evidence 
that cesarean section is protective of SUI recurrence in women with a MUS.
6.1.4 Study IV
The aim of Study IV was to evaluate and compare surgical and conservative treat-
ment in women with loss of level III support due to grade two perineal injuries. 
The results showed that surgical treatment leads to higher patient-reported global 
improvement rates. Surgery was also superior in curing pelvic floor and sexual 
dysfunction symptoms, as well as improving quality of life and psychological 
symptoms at 6 months after treatment.
There are a numerous amount of studies reporting outcomes of posterior compart-
ment procedures and they often mention perineorrhaphy being performed as a part 
of the operation when indicated. Kanter et al conducted a survey among gyneco-
logic surgeons attending the annual “Society of Gynecologic Surgeons” meeting 
in 2014, regarding factors of importance when deciding to perform a perineor-
rhaphy and details of their surgical technique.110 The authors found heterogeneity 
of practice patterns, both in terms of reasons for performing a perineorrhaphy 
and techniques for doing so. Many consider the perineal body to consist of the 
transverse perineal and bulbocavernosus muscles distal to the hymen. A total of 
60% of the responders noted that they perform levator muscle plication or attach 
the rectovaginal septum to the perineal body. 
Previous studies on perineal reconstructive surgery focus mainly on cosmetic 
outcomes and sexual enhancement.176 Validated questionnaires assessing pelvic 
floor dysfunction symptoms have not been used and no studies include a control 
group, which limits comparisons. Ulubay et al. described anatomical changes, 
patient satisfaction and sexual function in 38 women undergoing perineorrhaphy 
due to “a sensation of a wide vagina”.111 The patient satisfaction rate was 88% in 
comparison to 80% in the per-protocol analysis of the patients who underwent 
perineorrhaphy in our study. Christmann-Schmid et al published a study of 121 
patients undergoing posterior repair where preoperative perineal anatomy was 
categorized into three groups; normal perineum, short perineum and high/over-
compensated perineum.177 The study included 16 women with a short perineum (pb 
<2.5 cm) where the authors performed a posterior colporrhaphy plus a perineor-
rhaphy. The surgical technique included a diamond shaped excision of the perineal 
skin and mucosa distal to the hymen and surgically merging the detached perineal 
body structures to the midline. Patient reported treatment success, according to 
the Patient Global Impression of Improvement, was 95% at 6 weeks. However, 
they found no reduction in dyspareunia rates. 
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Dyspareunia is a known complication of vaginal surgery but it seems like a defec-
tively healed perineal body by itself is a risk factor for dyspareunia. Painful sexual 
intercourse was reported “often” or “always” by 42% of the patients included in 
our study compared to a prevalence of 7.5% in the general population.178 Studies 
have shown that the degree of perineal trauma during childbirth is correlated to the 
degree of dyspareunia at short term.179,180 Previous studies show conflicting results 
regarding de novo dyspareunia following posterior compartment procedures.181  
Secondary perineal repair has been shown to improve dyspareunia in a small cohort 
of women who developed postpartum dyspareunia after initial obstetric repair.182 
A total of 10% in the study by Ulubay et al reported de novo dyspareunia. Inan et 
al. studied changes in Female Sexual Function Index (FSFI) scores in 40 women 
undergoing perineoplasty.113 The technique included excision of scar tissue in the 
perineum, placing of bilateral levator ani sutures and approximation of the super-
ficial transverse perineal and the bulbocavernosus muscles.  The sexual function 
scores improved significantly, which is in concordance with our study, but they 
found no significant reduction in dyspareunia rates. Somewhat surprisingly, none of 
the patients undergoing surgery in our study reported de novo dyspareunia. Instead 
a total of 17/26 (65%) reported presence of dyspareunia sometimes, often or always 
preoperatively and only 8/28 (29%) postoperatively (p=0.01). Contributing to the 
low rate of de novo dyspareunia in our study compared to previous mentioned 
studies may be; minimal dissection when aiming to identify the disrupted perineal 
muscle ends, avoiding excessive excision of skin or mucosa distal to the hymen 
and not applying levator ani sutures.183  
The perineal membrane is intimately associated with the compressor urethrae and 
the urethrovaginal sphincter.18 An intact perineal body seems to be important in 
maintaining urinary continence.13 In total, 34/70 (49%) of the women included in 
our study reported moderately to greatly bothersome SUI at baseline. We found a 
significant reduction of SUI from 51% to 31% (p=0.005) 6 months after surgery. 
The results from this study thus supports a two-step approach, where a mid-urethral 
sling procedure could be postponed to a secondary operation in those patients with 
persisting bothersome SUI. Somewhat surprisingly, urinary symptoms did not improve 
significantly following physiotherapy, which is contradictory to many previous stud-
ies.101  This discrepancy could be explained by  an insufficient sample size in our 
study. It could also be that women with perineal body defects cannot contract the 
muscles surrounding the urethra as effectively as women with an intact perineum. 
The lower one-third of the posterior vagina is fused with the perineal body. 
Separation of fibers in the perineal body leaves the rectum unsupported and results 
in a low posterior prolapse.184 The anal canal may bulge and protrude out of the 
vaginal opening during defecation. At inclusion 16/35 (51%) in the surgery group 
reported that they have to push on the vagina or around the rectum to have a com-
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plete bowel movement. This number was reduced to 3/32 (9.4%) at 6 months after 
surgery but remained unchanged in the physiotherapy group. Other symptoms of 
obstructed defecation, like straining and feeling of incomplete emptying, were also 
highly prevalent in the study population but diminished significantly in the group 
receiving surgical correction of the anatomy. The prevalence of anal incontinence 
5 years after childbirth in women without a third or fourth degree tear has been 
reported to be as high as 32%.185 Flatus incontinence was reported by 49% of the 
study participants in our study, which is not surprising considering the intimate 
relationship between grade 2 perineal muscles and the anal sphincter complex. 
The rate of flatus incontinence decreased to 37.5% in the surgery group, but the 
reduction did not reach statistical significance. This could be explained either 
by the low sample size or the fact that anal incontinence is not always related to 
muscle defects but to neurologic impairment.186 
In conclusion, surgical compared to conservative treatment, was significantly 
and considerably more effective in women with second degree perineal defects 
after childbirth. Perineorrhaphy seems to reduce most pelvic floor dysfunction 
symptoms, as well as, improve quality of life, sexual functions and psychologi-
cal well-being, in women these women. The surgical technique (type of incision, 
removal of perineal skin or no, placing levator ani sutures or no) is, however, not 
standardized and future trials are needed to find the optimal approach.
6.2 METHODOLOGICAL CONSIDERATIONS
6.2.1 Internal validity – systematic error
Selection bias and misclassification
The study participants in Study I, II and III are selected from nationwide popula-
tion-based registers with excellent coverage and thus include the majority of patients 
in the source population. This minimizes bias occurring from how patients enter the 
studies. In all three studies the response rates might, however, introduce some degree 
of selection bias. Even though there is not one single cut off for a response rate 
that would secure unbiased results 187, as a general rule, response rates above 80% 
are considered good, while those between 60 and 80% are acceptable.188 Previous 
studies have concluded that non-responders have less severe symptoms.189,190 The 
response rates in Study I-III were 66%, 78% and 74% respectively. In all three 
studies, we performed a “non-responder analysis”, by comparing all demographic 
characteristics and exposure status between the responders and non-responders. 
We did not find any differences between the two groups. 
Missing values of possible confounding variables can also introduce selection bias.191 
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Study I had considerable problems regarding missing data. Important possible 
confounding factors had substantial proportions of missing values; BMI (23%), 
parity (22%), menopausal status (49%) and preoperative sensation of vaginal 
 bulging (19%). When we were in the process of building a regression model to 
control for possible confounding we lost almost half of our study subjects. We 
therefore adjusted for only age and ASA class in the main analysis and used the 
other variables in a regression model as a sensitivity analysis. After our study was 
published, many new reports on risk factors for prolapse recurrence are available. 
Using the updated knowledge about risk factors, we performed further sensitivity 
analyses with regression models including all known risk factors that were available 
in the dataset. This regression model had however 25% missing cases. A complete 
case analysis implicitly assumes that observations are missing completely at ran-
dom, which cannot be assumed. We therefore performed an additional analysis 
with multiple imputation of missing values. None of the sensitivity analyses did 
however significantly alter the results. 
The primary outcome in both Study I and II was cured prolapse defined as 
patient-reported absence of vaginal bulging symptoms at the 1-year follow-up 
questionnaire. The question “Do you experience a feeling of something bulg-
ing out of your vagina?” was dichotomized from five answer options (never or 
almost never into “no” and 1–3 times per month, 1–3 times per week or daily 
into “yes”). This question is validated for assessing symptomatic prolapse 125,192 
and an affirmative answer has shown to have a 84-96% sensitivity and 79-94% 
specificity for prolapse beyond the hymen.193,194 It has also been found to have the 
strongest correlation with patient-reported improvement and treatment success.60 
However, the optimal cut-off for cured and persisting clinically significant prolapse 
in unknown. We initially chose to categorize 1-3 times per month into treatment 
failure, whereas Bohlin et al categorized this into “no prolapse”.117 
One could also question the choice of vaginal bulging being our primary outcome 
when assessing cure after posterior colporrhaphy, since vaginal bulging might not 
be as specific for women with posterior prolapse. Common problems associated 
with a rectocele are symptoms related to obstructive defecation.43,50,52,132 Ellerkman 
et al reported, however, that bulging symptoms were the most specific symptom 
among women with prolapse regardless of compartment and the correlation between 
visualizing a bulge was as strong in the posterior as in the anterior compartment.43 
In our study, vaginal bulging was the most common symptom preoperatively (77-
79%). Further, we found no differences between the suture groups when comparing 
overall patient satisfaction or any of the symptoms related to obstructive defecation. 
Co-variates such as degree of prolapse and ASA class could possibly include some 
degree of misclassification since we don´t know if all surgeons reporting to the 
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register correctly classifies the degree of prolapse according to the standardized 
way described in the POP-Q system34 and some gynecological surgeons may not 
be entirely familiar with all the criteria in the ASA classification system. It is also 
possible that adverse events are underreported in the register. Also patient reported 
co-variates, such as weight, height and parity and especially smoking status, may 
include misclassification. However, we find no arguments for these misclassifica-
tions having a high probability of being differential.
The primary outcome in Study III (symptomatic SUI) is measured with a vali-
dated tool, the UDI. UDI and IIQ-7 questionnaires are “highly recommended” by 
the ICS as robust and appropriate questionnaires for evaluating symptoms and the 
quality-of-life effect of UI.127 Patients answering moderately to greatly bothersome 
symptoms on the question number three of the UDI (“Do you experience urine 
leakage related to physical activity, coughing or sneezing?”) correlate excellently 
to objective SUI in urodynamic testing.126 Milsom et al. identified 356 women 
who reported UI based on a postal survey and had them evaluated by clinicians 
who were blinded to the questionnaire responses. UI was confirmed by objective 
assessment in 94%, indicating that determine urinary incontinence by the ques-
tionnaire criteria is very likely to be clinically relevant.195  
In Study IV the exposures were pelvic floor muscle training compared to surgery. 
The group allocated to physiotherapy did receive coaching and evaluation of cor-
rect muscle training technique from trained health care professionals, but we did 
not measure if the patients actually performed the recommended muscle exercises. 
Nonadherence may thus lead to differential misclassification of the exposure. 
There is currently no validated objective outcome that defines success in treating 
women with symptomatic perineal defects and there is not one specific pelvic 
floor dysfunction symptom that is validated to determine cure versus treatment 
failure in this group of patients (in analogy with bulging sensation in women with 
POP). We therefore chose to use patient-reported global assessment of improve-
ment (PGI). This outcome has gained increasing popularity as an important out-
come in pelvic floor dysfunction research when assessing results of treatments. 
It has shown to strongly correlate with treatment success regarding management 
of other pelvic floor disorders.196,197 For obvious reasons the treatment allocation 
could not be blinded, which to some extent may introduce placebo effects. Since 
our primary outcome was purely subjective, patient expectations of symptom 
relief is likely to be affected by if the she was assigned to the treatment she was 
hoping for or believed in. 
The definition of a perineal defect is also not standardized. The height of the per-
ineal body in adult nulliparous women, according to the definition of the POP-Q 
system, ranges between 3.1-4.1 cm.198,199 We therefore chose to include women 
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with a perineal body height of <2cm in order to maximize the likelihood of the 
study subjects having anatomic defects of the perineum (34% had a perineal body 
height <1 cm and 66% less than 2 cm). The lack of nonblinded outcome assess-
ment may have caused measurement bias. 
Confounding
In Study I we used logistic regression in order to control for possible confounding 
factors. The regression models has been discussed in detail in previous chapters. 
Possible confounding variables that we haven’t been able to adjust for are for 
example the specific suturing technique, continuous or interrupted suturing and the 
number of sutures used in the mid-line plication. We did not adjust for surgeons 
experience, however, a recent study assessing surgical experience and results of 
single site, primary colporrhaphy procedures found no such association.200 We did 
not have data on other possibly important confounders such as levator ani injuries 
and genetic or hereditary factors. 
”Confounding by indication” is a term used when a variable is associated with the 
exposure status and at the same time a risk factor for the outcome. In Study II, 
there is a substantial risk for confounding by indication, since the presence of a 
cervical elongation, and not true apical decent, might be the reason for choosing 
cervical amputation instead of hysterectomy. Patients with only cervical elongation 
and adequate level I support, are probably less likely to suffer from recurrence. 
The register data unfortunately does not provide information about the presence 
of possible cervical elongation. Using the definition corpus uteri/cervix ratio of 
< 1.5  for cervical elongation 201, Berger et al found that cervical elongation was 
present in 98 % of patients undergoing hysterectomy due to objective and symp-
tomatic uterine POP stage II–IV. This suggests that the majority of the patients in 
our study in both groups had some degree of cervical elongation. 
In Study II the database did unfortunately not contain valid information regard-
ing how and if a suspension of the cuff/stump was performed during the surgical 
procedures, which could be an important confounding factor. Since preoperative 
prolapse stage is a strong risk factor for the outcome, we also tested the robustness 
of our results in strata of the four different grades of prolapse. 
In Study IV we used randomization to control for confounding, which is consid-
ered as the optimal approach to eliminate confounding. This design optimizes the 
probability of known and unknown confounders being distributed equally in both 
groups. However, it is worth noting that RCTs are not without their own biases, as 
illustrated by the “intent-to-treat” approach, where study participants are considered 
exposed to the assigned treatment, regardless of actual compliance. The intent-
to-treat analyses can minimize a real difference, generating bias towards the null.
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6.2.2 Precision
The precision in Study I and especially in Study II must be regarded as high due 
to the large sample size and a relatively high prevalence of the outcome (bulging at 
one year). This is reflected by the narrow CIs. However, when trying to adjust for 
multiple possible confounders in Study I, the sample size was reduced by 50% due 
to missing values in different variables, which remarkably lowered the precision 
of the estimates. The large sample size in Study II abled us to detect differences 
in rare outcomes, such as severe complications. Whether the negative results in 
Study III are explained by type II error is an inevitable question. We performed 
an a priori power calculation and the final sample size reached the desired level 
of power needed to detect a clinically relevant difference between the exposed 
and unexposed groups. We therefore argue that the risk of a type II error is low. 
The subgroup analysis of vaginal versus cesarean section after a MUS procedure 
might however lack sufficient power, although the difference in percentage points 
was zero (22% versus 22%), which strongly suggests that there is no difference 
between the groups. The sample size in Study IV is relatively small but nonethe-
less adequate, taking into consideration the large difference between the groups 
regarding the primary outcome. Interpretation of results of secondary outcomes 
must however be made with caution.
6.2.3 External validity
External validity reflects whether the conclusions of a scientific study can be 
applied outside the context of that study. In other words, it is the extent to which 
the results of a study can be generalized to other groups of peoples or settings. A 
crucial and often neglected variable in studies assessing outcomes after any surgical 
procedure is the experience and skills of the surgeon.202 A meta-analysis examining 
the associations between operating volume and outcomes found a positive correla-
tion regarding hysterectomies, gynecological oncology, surgical mesh complica-
tions, and incontinence procedures.203 The study participants in Study I, II and 
III are sampled from nation-wide registers, which have a strong external validity 
by the fact that they have high coverage and include “typical patients”. They often 
include more heterogeneous populations than those participating in RCTs (wide 
variety of age, ethnicity, and comorbidities). Especially when assessing outcomes 
of surgical procedures, register data can provide a good description of the true 
impact of interventions in actual practice, and not only in patients treated by few 
expert surgeons. The operating clinics varied from large-scale teaching hospitals 
to smaller private practices. In Study I and II we excluded secondary procedures, 
which limits the conclusions to patients undergoing primary procedures. 
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In Study III the majority of women had given birth only once after their MUS 
procedure, and thus conclusions cannot be generalized to women with multiple 
births after their incontinence procedure. Study IV is a single-center randomized 
trial, which limits the external validity. The procedures were performed by one 
of five different urogynecologists according to a structured protocol, and the 
pelvic floor muscle therapy sessions were tutored by two different physiothera-
pist. The results of the interventions are likely to be different when performed in 
other centers. We excluded for example women with connective tissue disorders, 
current use of systemic corticosteroids, diabetes mellitus and women who had 
undergone previous pelvic floor surgery. The mean age of the study population 
was 35 years, which limits generalization of outcomes of the procedure to older 
or postmenopausal women.
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7 CONCLUSIONS
The conclusions of the studies included in this thesis are:
I. The use of a slowly absorbable monofilament suture is associated with 
significantly higher odds of cured prolapse symptoms and higher rate of 
patient satisfaction one year after anterior colporrhaphy, as compared to 
the use of a more rapidly absorbable multifilament suture. The choice of 
suture material does not seem to affect patient-reported outcomes after 
posterior colporrhaphy.
II. Cervical amputaion seems to cure prolapse symptoms at one year after 
surgery as effectively as complete removal of the uterus, in women with 
apical decent.  However, vaginal hysterectomy is associated with a higher 
rate of severe complications and perioperative morbidity.
III. One preganancy and delivery after a mid-urethral sling operation does 
not seem to jeopardize the results from the incontinence procedure. The 
mode of the delivery subsequently to the incontinence procedure does 
not seem to have an impact on postdelivery continence status.
IV. Surgical correction of the anatomy in women with a poorly healed second 
degree perienal tear at least six months after childbirth, is considerably 
more effective then tutored physiotherapy in curing pelvic floor and 
sexual dysfunction symptoms. The surgical technique evaluated in this 
study does not seem to increase the risk of de novo dysparunia.
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8 ETHICAL CONSIDERATIONS
All four studies in this thesis were reviewed and approved by Regional Board of 
Ethics in Stockholm, Sweden (Dnr 2014/958-31/4 and Dnr 2015/1101-31/4).  All 
data was handled according to regulations in the Personal Data Act in Sweden 
(Swedish abbreviation: PUL). Data were anonymized and handled following rec-
ommendations for good clinical practice in data management. Results from all 
studies in this thesis are presented at an aggregated level.
According to Swedish law, research conducted using anonymized data retrieved 
from national registers can be used without informed consent from the study sub-
jects. In Study I-II, data from the GynOp register was delivered as anonymized 
data and individual patients could not be identified. Patients receive written infor-
mation about the register when scheduled for surgery and they have an opportunity 
to decline participation in the register. Patients also have the right to demand their 
personal information to be erased from the register. 
For Study III, the Swedish National Board of Health and Welfare conducted the 
linkage between the National Patient Register and the Medical Birth Register, 
in order to identify the eligible study population. The research question would 
not have been possible to answer without contacting the possible study subjects. 
Personal identity codes were therefore shared with the researcher in order to allow 
for postal questionnaires. Written informed consent was, however, obtained from 
the study participants in conjunction with the postal questionnaire. All electronic 
datasets containing personal identifiable information were password protected and 
only accessible to researchers involved in the study. For data entry and analyses, 
personal identity codes were substituted with unidentifiable codes. 
In Study IV, oral and written information was provided to the patients invited 
to participate in the study. Randomization was performed after informed written 
consent was obtained from the patient. Both treatments are a part of clinical prac-
tice for women with perineal defects. Participating in the study only means that 
one or the other treatment is randomly provided first. If the patient has persist-
ing symptoms at the 6 month follow-up she could cross-over to receive the other 
treatment. Further, participation in the study was completely voluntary and the 
patients were informed that they could drop out of the study, without explanation, 
if they would regret participation. 
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9 FURTHER PERSPECTIVES
The anterior vaginal wall is the most common site for prolapse and techniques 
using native tissue are the first line approach in surgical management of this condi-
tion. Considering the high failure rates after anterior colporrhaphy, it is crucial to 
conduct well-designed trials guiding evidence based standardization of technical 
details of this procedure. Prospective randomized trials with long-term follow-
up are needed to confirm the associations found in Study I. Another unexplored 
surgical detail is whether continuous versus interrupted suturing technique has an 
impact on the outcome. 
Anterior and apical compartment prolapse often co-exist. Future studies are war-
ranted to define which patients benefit from concomitant apical suspension. For 
example, in a woman presenting with primary anterior prolapse reaching just 
below the hymen and with a cervix that comes down to – 4 cm; what does the 
long-term risk-benefit ratio look like if an apical suspension procedure is added 
to the anterior colporrhaphy. 
One can choose from a variety of surgical procedures when treating women with 
apical prolapse. There are currently no evidence-based guidelines to aid the surgeon 
in this selection process. Two large randomized trials exploring surgical techniques 
when treating women with apical prolapse are currently ongoing in the Netherlands; 
one comparing laparoscopic sacrocolpopexy with sacrospinosus fixation in women 
with vault prolapse and one comparing the modified Manchester operation with 
sacrospinosus hysteropexy. Randomized trials comparing sacrohysteropexy with 
the Manchester-Forthergill procedure, as well as cost-effectiveness analyses, are 
needed to provide further evidence for the choice of uterus sparing procedures in 
women with apical decent. 
Regarding women with perineal defects there are multiple unanswered research 
questions. What is the optimal surgical technique when balancing symptom relief 
and the risk of dyspareunia? Should deeper levator ani sutures be used or not? 
The methodologies to study this group of patients need to be standardized and 
validated. A questionnaire designed to capture the symptomatology in women with 
grad 2 perineal defects is under the process of validation by a Swedish research 
group. Also studies assessing the normal and abnormal anatomy of the perineum 
using 3-dimensional ultrasound are ongoing. The results from these trials will 
be useful in order to fully describe the symptomatology and anatomy before and 
after surgical repair.
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10 POPULÄRVETENSKAPLIG 
SAMMANFATTNING
Bäckenbottendysfunktion innefattar symptom kopplat till framfall, urin- och 
avföringsinkontinens. Förekomsten av symptomgivande framfall uppskattas till 
6% och cirka 20% av kvinnor genomgår bäckenbottenkirurgi på grund av framfall 
eller inkontinens under sin livstid. Framfall innebär att lilla bäckenets inre organ, 
så som urinblåsa, livmoder och tarm, förlorar sitt stöd och buktar ner mot eller ut 
genom slidöppningen. Det vanligaste symptomet hos kvinnor med framfall är just 
en känsla av att något buktar ut ur slidan. Tyvärr får en betydande andel av kvin-
norna återfall trots framfallsoperation. Det saknas kunskap kring optimala kirurgiska 
tekniker för att hitta en bra balans mellan bot och potentiella komplikationer. En 
tämligen ostuderad subgrupp av kvinnor med bäckenbottendysfunktion är kvin-
nor med kvarstående skador på mellangården (perinealkroppen) som uppkommit 
i samband med en vaginal förlossning . Så kallad ”defektläkt perinealkropp” kan 
innebära att muskler som stödjer slidöppningen och tarmen tappat sitt fäste och 
därmed även sin funktion. 
Ansträngningsinkontinens innebär att muskler och vävnad som stödjer urinröret, 
helt eller delvis, förlorat sin funktion. Detta leder till att man inte lyckas stå emot 
eller kompensera för ett ökat tryck i bukhålan som uppstår vid t ex ansträngning, 
hosta eller nysning, vilket leder till ofrivilligt läckage av urin i samband med dessa 
situationer. Den vanligaste riskfaktorn för att utveckla ansträngningsinkontinens är 
vaginal förlossning och symptomen debuterar ofta efter att kvinnan fött sitt första 
barn. Det finns en effektiv kirurgisk behandling där man opererar in en stödjande 
nätslynga under urinröret (TVT operation) och upp till 80% upplever bot efter 
denna operation. Det saknats dock kunskap om effekten av nätslyngan förstörs 
av en efterföljande graviditet, samt om gravida kvinnor med ett inkontinensband 
skall rådas till att föda vaginalt eller med kejsarsnitt.
I denna avhandling har vi undersökt om valet av suturmaterial påverkar resultatet 
av en framfallsoperation. Vi har även studerat om kapande av enbart livmoder-
tappen (cervix amputation) leder till symptomlindring i lika stor utsträckning 
som borttagande av hela livmodern hos kvinnor med livmoderframfall. Vi har 
också undersökt om resultatet av en TVT operation påverkas av en efterföljande 
förlossning. Slutligen har vi studerat symptom före och efter kirurgisk jämfört 
med konservativ behandling, hos kvinnor som drabbats av en defektläkt grad två 
bristning efter en vaginal förlossning.
Studie I och II är baserade på data inhämtat ut det nationella kvalitetsregistret 
för gynekologisk kirurgi, det så kallade GynOp registret. I Studie I ingick 230 
kvinnor med framfall av främre vaginalväggen där kirurgen använde långsamt 
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absorberande monofilament sutur (LAS) och 501 där man använde snabbare 
absorberande multifilament sutur (SAS). En signifikant lägre andel kvinnor i LAS 
gruppen rapporterade en känsla av att något buktar ut ur slidan vid ett år efter 
operationen, 22% jämfört med 30% (p=0.01). I LAS gruppen var även en högre 
andel kvinnor nöjda med resultatet, 83% jämfört med 75% (p=0.03). Hos kvinnor 
som opererades för framfall av bakre vaginalväggen spelade valet av suturmaterial 
ingen roll för symptom vid ettårsuppföljningen. 
I Studie II undersökte vi resultat efter ett år hos 3174 kvinnor som opererats på 
grund av livmoderframfall. Totalt 1979 kvinnor där enbart livmodertappen kapats 
(cervixamputation) jämfördes med 1195 där hela livmodern bortopererades via 
slidan (vaginal hysterektomi). I bägge grupperna hade man hos majoriteten även 
gjort en samtidig framväggsplastik, eftersom livmoder- och framväggsframfall 
ofta samvarierar. Vi fann lika goda resultat i bägge grupper avseende bäckenbot-
tensymptom och patientnöjdhet vid ettårsuppföljningen. Däremot drabbades färre 
kvinnor i cervixamputationsgruppen av allvarliga kirurgiska komplikationer, 0.2 
jämfört med 2%. Cervixamputationsgruppen hade även kortare operations-, åter-
hämtnings- och vårdtid samt mindre blödningsmängd.  
I Studie III länkade vi uppgifter från det nationella patientregistret med det 
medicinska födelseregistret för att identifiera kvinnor som fött barn efter en TVT 
operation. Ur samma register identifierades även en kontrollgrupp, matchad för 
ålder och operationsår, där kvinnorna inte fött barn efter sin TVT-operation. Vi 
skickade ut validerade frågeformulär till bägge grupper för att kartlägga förekom-
sten av urinsymptom. Vi identifierade 207 kvinnor som fött minst ett barn efter 
en TVT-operation och 521 kontroller. Totalt 74% svarade på vår enkät. Vi fann 
ingen signifikant skillnad mellan grupperna avseende förekomst av ansträngn-
ingsinkontinens eller övriga urinsymptom. Vi fann heller inga skillnader mellan 
kvinnor som fött vaginalt och med kejsarsnitt efter en TVT-operation. Detta talar 
för att effekten av nätslyngan består om man föder ett barn efter sin operation och 
att man inte behöver rekommendera kejsarsnitt till denna grupp.
I Studie IV inkluderades totalt 70 kvinnor med symptomgivande, defektläkta 
grad två bristningar, där det gått minst sex månader efter den senaste förlossnin-
gen. Hälften lottades till handledd bäckenbottenträning och hälften till kirurgisk 
rekonstruktion, så kallad perineorafi med distal bakre plastik. De vanligaste 
symptomen hos de inkluderade kvinnorna var vaginal vidhetskänsla, slidpruttar 
och tarmtömningsbesvär, där kvinnorna var tvungna att trycka med ett finger i 
slidan eller mot mellangården för att kunna tömma tarmen. Vid uppföljningen 
efter 6 månader rapporterade signifikant fler i kirurgigruppen att de var mycket 
eller väldigt mycket förbättrade. Kirurgi var överlägsen konservativ behandling i 
att bota de flesta symptom inklusive samlagssmärta. 
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